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ABSTRACT 
Traumatic brain injury (TBI) is a serious public health concern. Although moderate 
and severe forms of TBI receive considerable attention, mild TBI accounts for the 
majority of all injuries. The first two aims of this work used a rodent model of mild 
blast to simulate primary injury (damage from the blast wave only). The first aim 
evaluated potential changes in interneurons containing the calcium-binding 
proteins calretinin or parvalbumin. In addition, morphological changes in 
astrocytes and microglia were assessed. Brains were analyzed 48 hours and one 
month following exposure to single or repeated blasts, with a focus on the 
hippocampus due to its integral role in learning and memory. Results showed 
significant region-specific alterations in microglia morphology 48 hours following 
blast. The absence of structural alterations in microglia one month following blast 
indicated that the regional hippocampal vulnerability may be transient. The second 
aim compared glial morphologies in the retina and brain (the lateral geniculate 
nucleus, superior colliculus, and visual cortex) 48 hours or one month following 
multiple blasts. Fiber degeneration has received considerable attention, however, 
 
 
vii 
less is known about the status of glia throughout the visual pathway following mild 
blasts. Although no structural alterations were detected, it is possible that 
alterations in glia occurred at a more acute time scale as changes in glia can be 
rapid and reversible.  
The final aim of this work focused on the immunocytochemical 
characterization of tau pathology in the visual cortices of human postmortem brains 
with advanced chronic traumatic encephalopathy (CTE). CTE is a devastating 
tauopathy associated with mild, repetitive TBIs. Although visual deficits are 
reported in CTE, the primary visual cortex is often spared. The main hypothesis 
under investigation was whether visual association areas would have tau 
pathology, despite sparing of primary visual cortex. In addition, a sub-class of 
interneurons containing parvalbumin was used to evaluate a potential cell-specific 
vulnerability. Results showed increased tau pathology in visual association areas 
in advanced CTE that was largely absent from the primary visual cortex. There 
was no effect on parvalbumin positive interneurons. The results of this work 
provide valuable insight regarding potential cell-specific resistance to CTE 
pathology. 
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CHAPTER 1 
INTRODUCTION 
 
What is traumatic brain injury? 
Traumatic brain injury (TBI) is a general term used to describe any alteration in the 
structure and/or function of the brain from an external force (McAllister, 2011; 
Xiong et al., 2013). Sources of external forces include auto accidents, falls, contact 
sports, and blast-related injuries in military settings (Andriessen et al., 2010; 
McAllister, 2011). Symptoms following a TBI may include headaches, dizziness, 
fatigue, vertigo, and sensory impairments to memory and vision (DeKosky et al., 
2013).  
TBI severity is commonly classified as mild, moderate, or severe 
(Andriessen et al., 2010). Recently, a fourth category, ‘penetrating’, has been 
added by the department of defense to differentiate damage resulting from 
penetration of dura (Leo and McCrea, 2016). Clinical diagnosis regarding the 
extent of injury is based on neurological examinations and neuroimaging 
(Andriessen et al., 2010; Zhang et al., 2016). Neuroimaging assessments include 
computed tomography (CT), magnetic resonance imaging (MRI), and diffusion 
tensor imaging (DTI) (Adrian et al., 2016). Each of the aforementioned imaging 
techniques infer specific advantages. MRIs allow clinicians to monitor changes in 
brain activity while DTIs provide a metric to evaluate nerve fiber integrity 
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(Andriessen et al., 2010). Though helpful in visualizing the areas where severe 
trauma occurred, CT scans are less useful in detecting subtle injuries. 
Clinically based scoring systems represent an important part of any 
neurological examination. The Glasgow Coma Scale (GCS) is a neurological 
scoring system that has been considered the gold standard since its inception in 
1974 (Majdan et al., 2015). It uses a 15 point scale to assess a patient’s motor, 
eye, and verbal responses following injury. The higher the GCS score the lower 
the severity of injury. Mild TBI has a GCS range of 13–15 (Andriessen et al., 2010) 
and is defined as confusion and/or disorientation that lasts less than 24 hours, a 
loss of consciousness less than 30 minutes, and post traumatic amnesia (PTA) 
less than 24 hours (Leo and McCrea, 2016). It has been reported that mild TBI 
represents the majority of all TBI cases (70–90%) (Ruff et al., 2009). However, the 
subtle deficits associated with mild TBI are not always detected by conventional 
neuroimaging (Ruff et al., 2009; Leo and McCrea, 2016). Moderate TBI entails 
confusion/disorientation over 24 hours but less than seven days, a loss of 
consciousness greater than 30 minutes but less than 24 hours and has a GCS 
range of 9–12 (Andriessen et al., 2010; Leo and McCrea, 2016). Similar to mild 
TBI, conventional neuroimaging results do not always detect structural 
abnormalities associated with moderate injuries (Leo and McCrea, 2016). Severe 
TBI is a confused/disorientated state and/or loss of consciousness that lasts more 
than 24 hours and has a GCS range less than or equal to 8 (Andriessen et al., 
2010; Leo and McCrea, 2016).  
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Experimental models used to study TBI  
Damage resulting from TBI is traditionally defined as primary or secondary (Patt 
and Brodhun, 1999). Immediate damage from the resultant force is defined as 
primary injury, while secondary injury is the delayed onset (minutes to months) of 
cascades initiated from the primary injury (Patt and Brodhun, 1999; Andriessen et 
al., 2010). The pattern of damage from a TBI is often described as focal or diffuse. 
Focal injuries such as hematomas (subdural and epidural), contusions, and 
hemorrhages arise from the force(s) exerted onto the skull that compresses 
underlying tissue at the location of impact (coup) or opposite the impact (contre-
coup) (Farkas and Povlishock, 2007; Andriessen et al., 2010). In contrast, diffuse 
(multifocal) injuries are widespread and exist in regions remote from the external 
force (Farkas and Povlishock, 2007; McAllister, 2011). 
Several animal models have been developed to simulate TBI. Each model 
is broadly defined as penetrating or non-penetrating based on the method used to 
produce injury.  
 
Penetrating models of TBI 
Fluid percussion injury (FPI) and controlled cortical impact (CCI) are two prevalent 
penetrating models of TBI (Figure 1.1). FPI uses a pendulum to strike a fluid filled 
reservoir that exerts a pulse of pressure from the fluid onto intact dura through a 
craniotomy centrally over the midline or laterally over the parietal bone between 
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bregma and lambda (Xiong et al., 2013). The strength of the pressure pulse 
determines the severity of injury. FPI is often used to reproduce focal injuries such 
as intracranial hemorrhage and to a lesser extent axonal injury (Finnie and 
Blumbergs, 2002; Xiong et al., 2013). In contrast to FPI, CCI is a rigid percussion 
model that employs a metallic piston to deliver a mechanical impact onto the intact 
dura (Cernak, 2005). The severity of injury is determined by the speed of impact 
and the extent of cortical deformation.  
 
Figure 1.1. Penetrating models of TBI. Schematic modified from Xiong et al., 2013. 
CCI = controlled cortical impact. FPI = fluid percussion injury. 
 
 
Non-penetrating models of TBI 
Weight drop 
To simulate concussive (mild) injury, several non-penetrating weight drop models 
have been constructed (Figure 1.2). Most use brass weights that are dropped from 
specified heights onto an exposed skull affixed with a steel protective disc located 
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centrally between bregma and lambda (Cernak, 2005; Hanrahan and Campbell, 
2016). Progressive injury associated with weight drop models correlates with the 
mass and height of the weight used. Injuries modeled from weight drop include 
both focal and diffuse axonal injury (Xiong et al., 2013). 
 
 
Figure 1.2. Common weight drop models of TBI. Schematic modified from Xiong 
et al., 2013. 
 
Blast  
TBI from blast exposures are categorized into four groups according to the nature 
of trauma. Primary injury is due to damage from the blast wave itself, secondary 
injury results from projectiles and penetrating fragments set in motion by the blast, 
while tertiary injury occurs from collisions with nearby objects, and quaternary 
injury is a consequence of burns and noxious fumes released from explosions 
(Chalioulias et al., 2007; Cernak and Noble-Haeusslein, 2010). Although primary 
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injury is known to cause neurological impairments, it remains the least understood 
type of injury (Elder and Cristian, 2009; Hicks et al., 2010; Svetlov et al., 2010; 
Courtney and Courtney, 2015; Nakagawa et al., 2016). In addition, primary injury 
is the most difficult to distinguish due to its co-occurrence with events that cause 
overt physical damage (Bhattacharjee, 2008). Because of this, many of the blast 
models to date focus on primary injury (Figure 1.3).  
Acceleration-deceleration, direct cranial transmission of the blast wave, and 
thoracic transmission are the main pathological mechanisms attributed to blast 
exposure (Goldstein et al., 2012; Gullotti et al., 2014; Courtney and Courtney, 
2015). Although neural damage due to acceleration-deceleration from blast waves 
traversing the skull is an accepted contributor of blast injury, thoracic transmission 
was initially the most widely cited mechanism. Thoracic transmission occurs when 
a blast wave propagates from the thorax to the head via major blood vessels 
(Simard et al., 2014). Although use of protective armor has significantly reduced 
injury via thoracic transmission, rotational and translational forces resulting in 
diffuse injuries remain prevalent contributors to injuries following blast (McAllister, 
2011) and can exacerbate pathology (Svetlov et al., 2010; Goldstein et al., 2012; 
Gullotti et al., 2014). In addition, rotational forces can shear and stretch neurons 
beyond their elastic threshold. Direct transmission of the blast wave through the 
skull is a significant factor in neural damage (Risling et al., 2011; Courtney and 
Courtney, 2015). Although evidence to support each mechanism exists, it is likely 
that they are not mutually exclusive.  
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Most of the blast related models focus on damage following exposure to a 
single blast (Cernak, 2005; Goldstein et al., 2012; Xiong et al., 2013). However, 
within the last decade it has become increasingly evident that injuries from multiple 
blasts can offer better insight into TBI pathology as injuries are often due to 
repetitive insults (Wang et al., 2011). Many animal models of blast use cylindrical 
shock tubes containing two chambers separated by a membrane (Figure 1.3). 
When the first chamber is pressurized with compressed air, the membrane 
ruptures producing a blast onto the restrained animal in the second chamber 
(Hanrahan and Campbell, 2016). Recently, modified blast models have employed 
simpler methods to generate blasts, increasing their ease of use and providing 
more control in delivering blasts (Figure 1.3) (Kuehn et al., 2011; Heldt et al., 2014; 
Sajja et al., 2014).    
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Figure 1.3. Blast models of TBI. General schematic of blast modified from Xiong 
et al., 2013. Blast tube and Shock tube images modified from Ning and Zhou, 2015. 
Images of custom fabricated devices modified from Kuehn et al., 2011 (left panel) 
and Heldt et al., 2014 (right panel). 
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Caveats from animal models 
Although the experimental use of animals to reproduce specific TBI pathologies is 
invaluable, differences in experimental design, animal choice, and anesthetics are 
increasingly recognized as confounding factors. 
 
Anesthetics and analgesics 
Anesthetics and analgesics are typically required to immobilize animals and 
minimize pain and distress during and after injury. However, commonly used drugs 
can significantly affect TBI outcome by exerting a continuum of neuroprotection 
(Rowe et al., 2013). It has been shown that mild TBI and acute recovery following 
injury show the greatest susceptibility to neuroprotective effects, particularly in the 
presence of volatile anesthetics such as isoflurane (Kawaguchi et al., 2005). Much 
of this neuroprotection is due to the ability of drugs to mitigate excitotoxicity 
(Kawaguchi et al., 2005). For example, the gaseous anesthetic isoflurane has been 
shown to reduce the release of glutamate in addition to blocking N-methyl-D-
aspartate (NMDA) and α-amino-d-hydroxy-5-methyl-4-isoxazole-propionate 
(AMPA) glutamate receptors in rats (Harada et al., 1999; Kimbro et al., 2000; 
Kawaguchi et al., 2005). In addition, the routinely used injectable anesthetic, 
ketamine, has been reported to significantly reduce memory dysfunction in TBI 
likely due to non-competitive inhibition of NMDARs that can mitigate deleterious 
consequences of their over-activation in a rat model of FPI (Smith et al., 1993). 
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Similarly, comparison of TBI outcome following the administration of seven 
commonly used anesthetics (diazepam, fentanyl, isoflurane, ketamine, morphine, 
pentobarbital, and propofol) in a rat model of CCI showed the least amount of 
neuronal death following exposure to isoflurane while ketamine treated animals 
had the greatest neuronal death (Statler et al., 2006). In contrast to evidence of 
neuroprotective effects, some studies report exacerbation of neurological 
pathology from anesthetics (Rowe et al., 2013). One study that evaluated the 
influence of isoflurane in a rat model of CCI found increased cell death that 
positively correlated with isoflurane dose and duration (Hertle et al., 2012). 
Although reports conflict regarding their benefit or detriment, awareness of the 
potential role that anesthetics and analgesics can have on TBI outcome is 
essential.  
 
Animal choice 
Animals used to study TBI have included: include pigs (Browne et al., 2011; 
Sherwood et al., 2014), rabbits (Jones et al., 2016), dogs (Shelah et al., 2007), 
mice and rats (Petras et al., 1997; Mohan et al., 2013; Zou et al., 2013; DeMar et 
al., 2016; Guley et al., 2016). Large animals such as pigs (Browne et al., 2011; 
Sherwood et al., 2014) and sheep (Xiong et al., 2013) can offer insight into the 
complex pathologies reported in humans due to similarities in brain size and the 
presence of sulci and gyri (gyrencephaly). However, mice are commonly used due 
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to their relatively low cost, ease of genetic manipulation, and well-mapped 
genomes (Steward et al., 1999; Cernak, 2005). In addition, studies using rats, 
though they offer less genetic manipulation in comparison to mice, are prevalent 
in animal models of TBI.  
An emerging consideration in rodent studies is the confound resulting from 
species and strain-specific differences (Steward et al., 1999; Bricker-Anthony and 
Rex, 2015). One study using FPI evaluated two commonly used rat strains, Fisher 
344 and Sprague-Dawley, found higher intracranial pressure, prolonged seizure 
activity, and significantly more degenerating neurons in Fisher 344 rats (Reid et 
al., 2010). Although C57BL/6 mice are most commonly used, and often serve as 
a background for many transgenic lines (Bricker-Anthony and Rex, 2015), work 
evaluating trauma in mice found a differential susceptibility to injury that can vary 
with strain and hybrid (Schauwecker and Steward, 1997; Majid et al., 2000). For 
example neurodegeneration and vision loss were more prevalent in DBA/2J mice 
compared with C57BL/6 (Bricker-Anthony and Rex, 2015). However, no 
standardization currently exists in model, anesthetic, or rodent strain. Therefore 
the aforementioned factors must always be considered when interpreting and 
comparing results. 
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Primary and secondary cellular pathologies resulting from TBI 
Although overt evidence of trauma such as contusions and lacerations have been 
detected postmortem, it has been well established that subtle cellular pathologies, 
evident only on a microscopic level, may be of greater importance to the 
progression of injury (Patt and Brodhun, 1999). Documentation of such pathologies 
includes but is not limited to cell death (Raghupathi, 2004; Andriessen et al., 2010; 
Wang et al., 2011), elevated free radicals (Huber et al., 2013), alterations in 
excitation and inhibition ratios (Buritica et al., 2009), and inflammation (de 
Lanerolle et al., 2011; Goodrich et al., 2016).  
 
Alterations in excitation and inhibition following TBI 
Increased permeability of cell membranes is believed to initiate pathological events 
that contribute to TBI (Johnson et al., 2010). Direct consequences of altered 
membrane permeability include the excessive release of excitatory transmitters 
and ion imbalances (Werner and Engelhard, 2007). Additionally, disproportionate 
excitation (excitotoxicity) can also contribute to pathological alterations in calcium 
ion homeostasis (Andriessen et al., 2010). Calcium ions are the most abundant 
second messenger with vital roles in cellular processes such as growth, 
development, and synaptic transmission (Weber, 2012). Persistent elevation in 
intracellular calcium can activate degradative enzymes such as proteases and 
detrimental mediators such as reactive oxygen species that exacerbate signaling 
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cascades that ultimately result in cell death (Zhivotovsky and Orrenius, 2011). 
Although logical to assume that excessive excitation results from alterations in 
excitatory cells as glutamatergic pyramidal cells represent 75–80% of neuronal 
cells type (Freire et al., 2015), considerable evidence exists to the contrary. While 
interneurons only account for approximately 20% of the neuronal population 
(Freire et al., 2015), their regulation of proper brain functioning is essential (Xu et 
al., 2010). Diminished and/or total loss of inhibition are considered major 
contributors to the excitoxicity that can result from TBI (Cantu et al., 2015).  
 
Inflammation 
Previously the brain was considered spared due to the presence of the blood-brain 
barrier (BBB), an impermeable barrier comprised of endothelial cells encased by 
glia (Cederberg and Siesjo, 2010). Disruptive forces from TBI and/or damage to 
cells that maintain the BBB can allow access of peripheral immune cells, 
pathogens, and cytokines, all of which can further exacerbate BBB breakdown 
(Obermeier et al., 2013). Results of neuroimaging in humans and staining assays 
in animal models of injury support compromised BBB integrity and the 
inflammation that ensues as a common consequence of TBI.  
Astrocytes and microglia are essential glial cell types involved in 
inflammatory responses following insults. Defining features common to both cell 
types are morphological changes (Figure 1.4) and secretion of soluble factors such 
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as cytokines, chemokines, and growth factors that modulate the extent of damage 
and repair following injury (Thored et al., 2009; Karve et al., 2016).  
 
 
Figure 1.4. Range of glial morphologies in response to changes in the 
microenvironment. Astrocytic phenotypes modified from Sofroniew, 2009. 
Microglial phenotypes modified from Thored et al., 2009. 
 
 
In healthy tissue, microglia are evenly distributed with dynamic properties 
that allow them to extend and retract thin (ramified) processes to survey their 
microenvironment (Jinno et al., 2007). In response to insult and interactions with 
neighboring cells, microglia can excrete soluble factors upon activation. Once 
activated, microglia can reversibly assume a variety of morphologies that range 
from hypertrophied somata and processes to complete contraction of processes 
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resulting in an amoeboid-like appearance (Figure 1.4, bottom panel) (Thored et 
al., 2009; Karperien et al., 2013). The spectrum of microglia polarization is broadly 
classified as cytotoxic M1 (classical activation) or neuroprotective M2 (alternative 
activation/acquired deactivation) (Tang and Le, 2016). The specific identity of 
microglia is based on a combination of secreted mediators, cell surface receptors, 
and alterations in gene expression. Similar to microglia, astrocytes normally tile 
the brain (Sofroniew and Vinters, 2010) and can undergo morphological changes 
(Figure 1.4, top panel) following insult and alterations in surrounding cells. In 
addition, astrocytes can secrete factors that affect the microenvironment and 
overall tissue integrity (Chen and Swanson, 2003). Studies evaluating astrocytes 
and microglia in the context of disease and trauma have demonstrated that 
responses are context and severity dependent (Schwartz et al., 2006; Zamanian 
et al., 2012). The autocrine and paracrine responses of astroglial reactivity can 
infer beneficial effects (neuroprotective) or exert deleterious (neurotoxic) 
exacerbation of cellular cascades (Karve et al., 2016).  
 
Long term complications associated with TBI  
The complex processes underlying TBI have been implicated in the initiation of 
long-term cognitive deficits (Faden and Loane, 2015).  Specific neurodegenerative 
disorders following TBI include: amyotrophic lateral sclerosis, Alzheimer’s disease 
(AD), Parkinson’s disease, and chronic traumatic encephalopathy (CTE), the latter 
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of which is uniquely associated with repetitive head injuries (DeKosky et al., 2013; 
Elder et al., 2014; Faden and Loane, 2015). 
Specific cellular events linking TBI with long-term neurodegenerative 
disorders center on the progressive accumulation of similar pathological 
components. Several studies have focused on the accumulation of amyloid 
precursor protein (APP) and amyloid-beta (Aβ) fragments that result from APP 
cleavage (Johnson et al., 2010; O'Brien and Wong, 2011). Accumulation of APP 
and Aβ plaques are common in degenerative disorders that are associated with 
TBI such as AD, and have been found soon after injury in animal models of TBI 
(Johnson et al., 2010). Results of one study found increases in Aβ 
immunoreactivity that persisted one month to one year following FPI in adult rats 
(Iwata et al., 2002). Interestingly, Aβ was found to accumulate in the absence of 
upregulated APP gene expression, suggesting a possible mechanism to account 
for neurodegeneration following TBI. In addition to APP and Aβ, a number of TBI 
studies have focused on accumulation of tau (Goldstein et al., 2012; McKee et al., 
2013). Tau proteins are microtubule-associated proteins that function to stabilize 
microtubules (Avila et al., 2004). Figure 1.5 compares tau proteins in a healthy and 
disease neuron. Following trauma, or other pathological insults, deleterious 
aberrations such as hyperphosphorylation destabilize tau proteins causing them 
to disassociate from the microtubule and aggregate in the form of tangles and/or 
filaments in and around neurons and glia (Avila et al., 2004; Forman et al., 2005). 
Toxic accumulation of tau results in compromised axonal transport that contributes 
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to synaptic dysfunction, and ultimately degeneration (Ballatore et al., 2007). 
Particularly devastating is the ability of hyperphosphorylated tau to sequester 
normally functioning tau proteins leading to progressive retrograde 
neurodegeneration (Iqbal et al., 2005). Disrupted axonal integrity is posited to 
underlie the long-lasting cognitive deficits following TBI (DeKosky et al., 2013). 
Structural disorganization of axons can occur immediately following insults and/or 
over long intervals following injury (Iwata et al., 2002). However, environmental 
and genetic factors are emerging as active areas of research due to the variation 
and presentation of long-term impairments associated with single-incident versus 
repetitive TBIs. 
 
 
Figure 1.5. Function of tau proteins. In a healthy neuron (left), tau proteins stabilize 
microtubules supporting axonal transport. In contrast, in a diseased neuron (right) 
post-translational modifications such as hyperphosphorylation cause tau proteins 
to disassociate from microtubules resulting their disassembly, impaired axonal 
transport, and aggregations of tau, which ultimately contribute to 
neurodegeneration. Schematic modified from Lim et al., 2014.  
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Challenges to therapeutic approaches of TBI and associated long-term 
disorders 
Therapies in development target specific cellular pathways believed to contribute 
to injury progression (Kochanek et al., 2015; Xiong et al., 2015; Aertker et al., 
2016). However, mechanisms once thought to be detrimental can also be 
beneficial, such as some inflammatory processes (Xu et al., 2011; Xiong et al., 
2015; Tang and Le, 2016). Complications due the type of injury, severity of injury, 
age, gender, pre-existing diseases, other comorbidities, and small samples sizes 
in clinical studies are often unavoidable (Xiong et al., 2015). Candidate biomarkers 
serving as proxies for neuronal injury (neuron specific enolase and tau) and glial 
injury (glial fibrillary protein and S100β) have emerged (Zetterberg et al., 2013). 
The determination of biomarkers present in cerebrospinal fluid, blood, and/or urine 
could aid in rapid assessment of the temporal characteristics of injury profiles, and 
allow monitoring of the efficacy of therapeutic interventions (Adrian et al., 2016). 
In spite of considerable progress in identifying cellular pathologies following TBI 
and related long-term disorders, clinical breakthroughs in treatments and 
mitigation have been delayed. The heterogeneous nature of TBI and the limitations 
of transitioning experimental success in animal models into clinical practice remain 
a challenge in designing effective treatments (Menon, 2009). 
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Summary of specific aims 
The objectives of this work were to evaluate the cellular changes in a previously 
validated rodent model of mild direct cranial blast and in human postmortem brains 
diagnosed with advanced stages of CTE to carry out the following three aims: 
 
1. Immunocytochemically evaluate neuronal and glial responses in the mouse 
hippocampus following acute (48 hour) and chronic (one month) exposure to a 
single and repeated mild blast pressures (Chapter 2). 
 
Vulnerability of the hippocampus following TBI has been widely documented (Royo 
et al., 2006; Sajja et al., 2014). The goal of this aim was to use neuronal and glial 
markers to evaluate cellular responses following acute (48 hours) and long-term 
(one month) exposure to single versus repeated blasts using a previously validated 
rodent model of blast injury (Kuehn et al., 2011).  
Inflammation is a prevalent consequence following TBI. Several studies 
have cited the roles of astrocytes and microglia in eliciting immune responses 
following injury (Karve et al., 2016). In addition to inflammation, alterations in 
calcium ion homeostasis are prevalent consequences following TBI that have been 
implicated in apoptotic and necrotic cascades that result in cell death (Buritica et 
al., 2009; Weber, 2012; Karve et al., 2016). To evaluate glial response to injury 
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glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule-
1 (Iba-1) were used to label astrocytes and microglia, respectively. The calcium-
binding proteins calretinin and parvalbumin were used to selectively label large 
populations of non-overlapping inhibitory cells. 
 
2. Establish whether astrocytes and microglia are similarly affected in the brain and 
retina following exposure to mild repetitive blast pressures (Chapter 3). 
 
As an accessible part of the central nervous system it has been speculated that 
the retina may provide insight into the central damage following injury. Although 
fiber degeneration has received considerable attention due to the DAI that is 
common following injury, less is known about the status of glia throughout the 
visual system. Thus, the goal of this aim was to compare glial morphologies in the 
retina and select brain regions essential for visual processing (the dorsal lateral 
geniculate nucleus, superior colliculus, and visual cortex) in a mouse model of 
blast-induced TBI following acute (48 hours) and long-term (one month) recovery 
to repetitive blasts.   
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3. Immunocytochemically evaluate the extent of tau pathology in visual cortices 
and determine whether a specific sub-group of interneurons are structurally altered 
in advanced CTE (Chapter 4). 
 
No study to date has documented tau pathologies beyond the primary visual 
cortex, which is found to be spared except in the most severe cases (McKee et al., 
2013). In addition, work exploring vulnerability of specific interneuronal populations 
in CTE is lacking. Thus, the goals of this aim were to determine the extent of tau 
pathology present in visual association areas and identify if a specific sub-class of 
GABAergic neurons containing the calcium-binding protein parvalbumin are 
affected in advanced stages of CTE. 
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CHAPTER 2 
Immunocytochemical evaluation of neuronal and glial responses in the mouse 
hippocampus following single and repeated blast exposures 
 
ABSTRACT 
Hippocampal abnormalities resulting from TBI have been widely documented in 
several animal models. In this study immunocytochemistry was used to examine 
structural alterations in neurons containing the calcium-binding proteins calretinin 
and parvalbumin. Glial populations of interest were astrocytes and microglia. The 
time points evaluated were 48 hours (acute) and one month (chronic) following 
single and repeated blasts. Though statistically insignificant, results showed 
subtle, subthreshold, effects of blast within hippocampal interneurons. Of the 
different hippocampal regions surveyed, the stratum lacunosum moleculare and 
the outer molecular layer of the dentate gyrus showed statistically significant 
changes acutely following blast in both of the glial populations examined. Overall 
the findings from this study indicate a regional hippocampal vulnerability that may 
be transient. Future studies focused on the anatomical and functional responses 
to blast at more acute recovery time points (less than 48 hours) are clearly 
warranted.   
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INTRODUCTION 
Anatomy of the hippocampus 
The hippocampus is a bilateral structure integral to memory and spatial navigation 
(Strange et al., 2014). Technically, the hippocampus is part of a larger network 
called the hippocampal formation. Functionally, each part of the network has a 
distinct role in information processing. The hippocampal formation comprises the 
following adjacent regions: entorhinal cortex, parasubiculum, presubiculum, 
subiculum, dentate gyrus, and the hippocampus proper: cornu ammonis 1, 2, and 
3 (Andersen, 2007). Each area differs in its cytoarchitecture, function, and 
projections. The seemingly simplistic allocortical (less than six layers) laminar 
organization and input from a diverse array of neocortical regions have rendered 
the hippocampal formation a widely studied network (Forster et al., 2006).  
Hippocampal formations are somewhat grossly similar across several 
mammalian species. However, significant species specific differences exist in the 
number of cytoarchitectural sub-divisions, cell densities, neuroanatomy, and tissue 
volume(Andersen, 2007). Though works documenting hippocampal neuroanatomy 
in monkeys and humans exist, much of our understanding is based on rodents, 
specifically rats (Andersen, 2007). While mice offer unparalleled genetic 
manipulations, compared to rats, it is commonly assumed that the similarities 
between rodents outweighs the potential confounds due to species and strain 
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specific differences, although this belief is being challenged. However, this study 
focused on general hippocampal organization as it relates to rodents.  
 The rodent hippocampus is a curved, elongated, structure that runs 
longitudinally along a dorsoventral (or rostralcaudal) axis (Figure 2.1). Based on 
differences in cortical and subcortical connections and lesions studies, the dorsal 
hippocampus is implicated in spatial learning while the ventral hippocampus is 
believed to mediate emotional responses (Moser et al., 1993; Fanselow and Dong, 
2010). It is worth noting that region-specific functional differences are not absolute 
nor a simple dichotomy but rather a complex and gradual functional spectrum 
along the longitudinal axis (Risold and Swanson, 1996). 
Although the term ‘hippocampus’ is somewhat ambiguous and can differ 
based on context, it is commonly used as a reference for the cornu ammonis sub-
fields described by the neuroanatomist Lorente de Nó (Andersen, 2007). However, 
in this work the term ‘hippocampus’ will be used to collectively denote the dentate 
gyrus (DG), cornu ammonis 3 (CA3), and cornu ammonis 1 (CA1) as the 
aforementioned are the hippocampal sub-fields that are the focus of the present 
work. Despite substantial controversy regarding the existence of cornu ammonis 2 
(CA2), evidence supporting its presence as distinct, yet narrow, sub-field located 
between CA1 and CA3, exists but it was not examined in this study. 
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Neurons in the hippocampus  
The principle cell type in the hippocampus is a relatively homogenous population 
of pyramidal cells (granule cells in the dentate gyrus) (Klausberger and Somogyi, 
2008).  Non-principal inhibitory interneurons represent approximately 10–20% of 
the total neuronal population within the hippocampus (Chamberland and Topolnik, 
2012). Although a small minority, interneurons have a significant role in 
coordinating cellular activity that affects the overall functionality of the 
hippocampus (Freund and Buzsaki, 1996). Spatially, interneurons are found 
scattered throughout all sub-fields and maintain local synaptic contact with 
principle cells in addition to other interneurons (Jones and Yakel, 1999).  
The diversity of interneuron populations has been documented and is based 
on differences in electrophysiology, location, morphology, cell and molecular 
markers, and, more recently, single cell sequencing of ribonucleic acids (Zeisel et 
al., 2015). Given the sparse yet diverse interneuronal cell types exerting a powerful 
influence on the overall status of the hippocampus, this study examined whether 
two non-overlapping populations of interneurons, identified by the presence of the 
well-established calcium-binding proteins parvalbumin and calretinin, were 
affected following exposure to mild blasts. 
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Hippocampal vulnerability to injury 
The hippocampus is affected in several neurological conditions and disorders such 
as epilepsy (Huusko et al., 2015), seizures (Kovacs et al., 2014), Alzheimer’s 
disease (Morrison and Hof, 2002), and chronic traumatic encephalopathy (McKee 
et al., 2013). Vulnerability of the hippocampus to damage following TBI (Royo et 
al., 2006; Atkins, 2011; Sajja et al., 2014) has been has been attributed to its 
anatomical position (Almeida-Suhett et al., 2015) and biochemical diversity 
(Geddes et al., 2003). However, most TBI studies employ invasive models of focal 
injury and/or moderate to severe blast models.  Although most reports of structural 
hippocampal changes are based on results of moderate and severe forms of TBI, 
mild TBI accounts for over 80% of all injuries (Almeida-Suhett et al., 2015) and 
damage is often subtle and/or transient. In general, shifts in excitation and 
inhibition ratios, due to a loss of inhibition, and glial activation are two commonly 
cited mechanisms of injury within the hippocampus (Beamer et al., 2016). 
 
Study objectives 
The main goals of this study were to use immunocytochemistry to characterize the 
extent of structural alterations in neurons containing calretinin and parvalbumin.  
The rationale for examining these neuronal populations was based on the 
prevalence of altered inhibition following TBI. 
27 
 
 
In addition to alterations in interneuronal populations, inflammation is a 
prevalent consequence of injury, as stated in Chapter 1. Several studies have cited 
the roles of astrocytes and microglia in eliciting immune responses following TBI 
(Karve et al., 2016). Thus, antisera directed against glial fibrillary acidic protein 
(GFAP) and ionized calcium binding adapter molecule-1 (Iba-1) were used to label 
astrocytes and microglia, respectively.  
Both neuronal and glial populations were evaluated following exposures to 
single and repeated blasts using a previously established rodent model of direct 
cranial blast injury (Kuehn et al., 2011) at acute (48 hours) and long-term (one 
month) survival times. The choice to focus on the hippocampus was based on the 
prevalence of hippocampal vulnerability following TBI and the lack of studies 
focused on structural alterations in neurons and glia following exposure to blasts 
in the absence of anesthetics.  
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Figure 2.1. Rodent hippocampus. (A) General schematic of a rodent brain 
depicting the position of the hippocampus along its longitudinal dorsoventral axis 
relative to other brain regions. (B) Isolated hippocampi (left) and corresponding 
coronal sections (right). CA1 = cornu ammonis 1. CA2 = cornu ammonis 2. CA3 = 
cornu ammonis 3. EC = entorhinal cortex. s=septal. S= subiculum. t=temporal. 
Schematic modified from Cheung et al., 2015.  
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METHODS 
Blast Wave Measurements and Calibration 
A precision dynamic high frequency piezoelectric pressure transducer (Model: 
113B21 High Frequency ICP® pressure sensor, PCB Piezotronics, Inc., Depew, 
New York) was used to calibrate blast waves produced by the Cranium Only Blast 
Injury Apparatus (COBIA), (Figure 2.2A). The sensor was positioned where the 
head of the mouse would be inside the apparatus. A constant current supply 
(Model 5421, Columbia Research Laboratories, Inc., Woodlyn, PA) provided 
power to the transducer. Outputs were digitized using an analog to digital converter 
(Analog Devices, ADAS3022) before saving waveforms for offline analysis. The 
average blast overpressure was 1,034 kPa (Figure 2.2B). 
 
Blast procedure 
All procedures were approved by the Institutional Animal Care and Use Committee 
at Boston University. 
1. Adult C57BL/6 mice (2–6 months) were acclimated for 72 hours upon arrival to 
the Boston University animal facility where they were ear tagged while 
anesthetized with isofluorane.  Mice were then acclimated for five days prior to 
experimentation to eliminate potential confounds from the presence of anesthesia.  
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2. The COBIA was used to generate blast overpressures as described and 
characterized previously (Kuehn et al., 2011). The central component of the 
COBIA was a .22 caliber, single-shot, powder-actuated tool (Ramset RS22; ITW 
Ramset, Glendale Heights, IL) modified by removing the piston that normally drove 
the fastener, causing it to function like a firearm allowing the blast wave to 
propagate un-dampened through the barrel. The tool was held vertically using a 
custom-fabricated stand, which also ensured its safe use. The blast was directed 
downwards into a blast dissipation chamber (BDC) that interfaced snugly with the 
muzzle of the tool (Figure 2.2A). The BDC was fabricated from polyvinyl chloride 
piping that directly delivered the blast overpressures onto the dorsal surface of the 
head.  The blast wave was generated by firing a .22 caliber crimped brass cartridge 
(power hammer loads power level 4, yellow color coding, with 179 ± 5mg of 
smokeless powder). 
All animals were weighed prior to experimental use. A mouse cylindrical 
restrainer (Stoelting Co. Wood Dale, IL) was used to immobilize the animals. 
Custom paper cones were fitted and wetted around the head to prevent potential 
quaternary damage from gunpowder during blasts. Once restrained, animals were 
inserted with the cranium positioned two (2) centimeters from the opening of the 
BDC. Blasts were directed between bregma and lambda. Sham animals represent 
mice treated identically to the blast exposed mice with the exception of exposure 
to injury.  
As outlined in Figure 2.2C, the experimental timeline of this study centered 
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on evaluating neuronal and glial responses following acute (48 hours) and chronic 
(one month) exposures to a single blast and three blasts with 24 hour latencies.  
 
Tissue Preparation  
When the specified recovery time point was reached, mice were anesthetized with 
isofluorane (Butler Schein) prior to perfusion with heparinized saline (0.9% sodium 
chloride in distilled water) followed by 4% paraformaldehyde in 0.1 M phosphate 
buffer (PB, pH 7.4). Immediately after perfusion mice were decapitated, brains 
were harvested intact and immersed in 4% paraformaldehyde overnight at 4˚C.  
After immersion fixation intact brains were cryoprotected in PB containing 
sucrose concentrations gradually increased from 5% to 30% overnight at 4˚C.  
Brains were dissected from bregma -0.94mm to -2.92mm using an adult mouse 
brain slicer matrix (BSMAS001-1, Zivic Instruments, Pittsburgh, PA). Serial coronal 
sections (40 µm) were obtained using a freezing sliding microtome (Reichert Jung) 
and stored in individual wells of a 96-well plate containing cryoprotectant (30% 
sucrose (Sigma), 30% ethylene glycol (Fisher), 1% polyvinylpyrrolidone (Sigma) in 
Tris-buffered saline pH 7.6 (0.4M Trizma HCl, Sigma, 0.01M Trizma base, Sigma, 
0.15M Sodium Chloride, Fisher) at -20˚C prior to histology and immunostaining.  
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Histology 
To evaluate potential changes in cytoarchitecture, two coronal slices containing 
dorsal (bregma -1.46 to -1.70mm) and ventral (bregma -2.80 to -3.16mm) 
hippocampi were selected. Slices were matched according to Franklin and 
Paxinos, 2008. Sections were slide mounted, air-dried overnight and then defatted 
in chloroform:ethanol (1:1), rehydrated, and counterstained using 0.05% thionin 
(pH 4.8) to stain Nissl substance as previously described (Giannaris and Rosene, 
2012).  
 
Immunocytochemistry 
Three to five slices from each animal, spanning dorsal, bregma-1.46 to -1.70mm, 
(Franklin and Paxinos, 2008). Hippocampi were washed extensively in PB to 
remove residual cryoprotectant and then mounted and air-dried onto Colorfrost 
Plus subbed slides (ThermoFisher Scientific, Waltham, MA). Slices were 
rehydrated in PB and endogenous peroxidase was quenched using 3% hydrogen 
peroxide in PB before incubation in 5% normal donkey serum (Jackson 
ImmunoResearch Laboratory, Inc. West Grove, PA) diluted in PB-0.3% Triton X-
100 (PBTx, Sigma) for one hour at room temperature. Following blocking, slices 
were incubated overnight at 4˚C in primary antisera directed against GFAP (GFAP 
1:250, Clone No. N206 A/8, UC Davis/NIH NeuroMab Facility Cat# 75-240, 
RRID:AB_10672299) and Iba-1 (1:1000, Wako, Catalog No. 019-19741).  
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Chromogenic detection   
After incubation in primary antisera slices were washed in PB and the appropriate 
biotinylated secondary antisera was applied (donkey anti-mouse (Jackson 
Immuno Research, Catalog No. 715-065-137) or donkey anti-rabbit (Jackson 
Immuno Research, catalog No. 711-065-152) both diluted to 1:500 in 0.3% PBTx) 
for one hour at room temperature. Following incubation in biotinylated secondary 
antisera, the tissues were incubated for 90 minutes in Neutravidin conjugated to 
horseradish peroxidase (diluted 1:250 in PBTx; ThermoFisher Scientific).  
Chromogenic detection was carried out using Metal-Enhanced 3’3’-
diaminobenzidine (DAB) substrate (diluted 1:10 in stable peroxide buffer, Pierce 
Chemical Company, Rockford IL). DAB development was stopped by immersion 
in several changes of 0.1M PB. Slices were then rinsed in distilled water and 
coverslipped in Gelvatol (10% polyvinyl alcohol, Sigma; 20% glycerol, Sigma; 
0.02% sodium azide, Fisher; 0.2M Tris, Amresco, pH 8.5). 
 
Fluorescence detection 
Following incubation in primary antisera, the sections were washed in PB and then 
incubated in the appropriate fluorescently conjugated secondary antisera (donkey 
anti-mouse Cy3 (Jackson Immuno Research, Catalog No. 715-165-150) or donkey 
anti-rabbit 647 (Jackson Immuno Research, Catalog No. 711-605-152), both 
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diluted to 1:500 in 0.3% PBTx) for two hours at room temperature. Slices were 
then coverslipped in Gelvatol and imaged within 24 hours.  
 
 During chromogenic and fluorescence immunostaining, some slices were 
stained without primary antisera to ensure antigen specificity. Slices not exposed 
to primary antisera were negative for immunoreactivity indicating that the signal 
observed was specific to the antigens probed. The specificity of these primary 
antisera in mice have been published previously (Jinno and Kosaka, 2002; Jinno 
et al., 2007). 
  
Imaging  
Fluorescently labeled hippocampal sections were imaged using the same laser 
and sensitivity settings on an Olympus BX61 spinning disk confocal (Olympus 
Corporation) using 10x and 40x water immersion, or a Nikon Eclipse motorized 
microscope (Nikon Instruments, Inc.) at 4x, 10x, and 20x.  
 
Analysis 
ImageJ software (U.S. National Institutes of Health, Bethesda, Maryland, USA) 
was used to analyze immunostained slices. CorelDraw (X6) was used to label and 
arrange images.  
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Cell Counting 
Cells positive for calretinin and parvalbumin within cornu ammonis 1 (CA1) and 
cornu ammonis 3 (CA3) within a 20x field were manually counted in each 
hemisphere. Total cell counts were averaged by animal and then by condition. 
 
Densitometry 
To quantify potential differences in the density of neuronal process densitometry 
was performed. Signal intensities were matched across images. Fluorescent 
images were inverted such that signal appeared black. For calretinin 
immunostaining ROIs containing the inner molecular layer and granule cell layer 
were rotated to obtain vertical averages for each image using the plot profile 
feature in Image J (Figure 2.3 B). Grand averages were created from data obtained 
for each condition (sham versus blast). To assess parvalbumin positive 
immunoreactivity in the inner molecular layer of the dentate gyrus, ROIs containing 
processes only (Figure 2.4), were matched across images and the mean gray 
value was obtained. Values were averaged by animal and then by condition. 
 
Percent Area  
Four RGB (red, green, blue) multi-channel images within each ROI were obtained 
at 20x. All images were converted to single channel images. The channel with the 
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greatest signal to noise contrast (blue) was selected and used across all groups. 
All single channel (grayscale) images were made binary using a threshold overlay 
(Figure 2.5). The area fraction, defined as the percent coverage (percent area) of 
immunoreactivity within each ROI, was obtained for each binary image using the 
area fraction selection from the ImageJ "Measure” feature. It was hypothesized 
that hypertrophy due to glial activation would be reflected by a greater percent 
area. Values obtained for each ROI were averaged by animal and then by 
condition (sham versus blast).  
 
Semi-quantitation of Iba1 Phenotypes 
The total number of Iba-1 cells were categorized in based on three broad 
morphological groups: ramified, hypertrophic, and amoeboid (Karperien et al., 
2013). Manual counts of Iba-1 positive cells were averaged for each animal and 
then averaged by group.  
 
Statistics 
An analysis of variance (ANOVA) with a Bonferroni post hoc correction was used 
(SPSS v24, IBM Corp.) to establish whether differences were present between 
sham and blast exposed mice (p<0.05).  
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Figure 2.2. Experimental design. (A) The Cranium Only Blast Injury Apparatus 
(COBIA) used to generate blast overpressures. (B) Pressure waveform produced 
by the COBIA revealing average peak overpressure of 1,034 kPa. (C) Timeline of 
experimental paradigm. Animals were sacrificed after Blasts 1 (single blast 
paradigm) or Blast 3 (repetitive blast paradigm) following a 48 hour (acute) or one 
month (chronic) recovery. BDC = blast dissipation chamber. 
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Figure 2.3. Calretinin immunoreactivity. (A) Representative low magnification 
image of calretinin immunostaining in the mouse hippocampus. The black box 
represents the sub-region sampled for vertical averaging, scale bar = 100 µm (B) 
Representative ROI from (A) rotated for vertical averaging of immunoreactivity, 
scale bar = 20µm (C) Vertical average of immunoreactivity detected in the granule 
cell layer and inner molecular delineated by vertical dashed lines. A.U. = arbitrary 
units. CA1 = cornu ammonis 1. CA3 = cornu ammonis 3. DG = dentate gyrus. ROI 
= region of interest. 
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Figure 2.4. Parvalbumin immunoreactivity. (A) Representative low magnification image of parvalbumin 
immunostaining in the mouse hippocampus. Enclosure represents sub-region sampled for densitometry (white 
rectangle), scale bar = 100 µm. (B) Inset from (A) containing representative ROI (white rectangle) sampled, scale 
bar = 20µm. CA1 = cornu ammonis 1. CA3 = cornu ammonis 3.   DG = dentate gyrus. ROI = region of interest. 
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Figure 2.5. GFAP immunostaining. Grayscale image of GFAP immunostaining (left). Zoom of ROI analyzed (top 
right panel). Example threshold overlay (right middle panel) and resulting binary image (right bottom panel). CA1 = 
cornu ammonis 1. CA3 = cornu ammonis 3. DG = dentate gyrus. GFAP = glial fibrillary acidic protein. Scale bar = 
250 µm. ROI = region of interest. 
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RESULTS  
Hippocampal cytoarchitecture unaffected following blasts 
A thionin stain was performed in order to determine if exposure to blast(s) affected 
cytoarchitecture. Hippocampi from sham and blast exposed mice were closely 
examined for gross differences in thionin staining. No apparent differences in the 
densities of cells or lamination of sub-fields were found. Lack of detectable 
differences in sham and blast exposed animals confirmed that acute and chronic 
recovery from a single blast as well as three consecutive blasts were insufficient 
to detectably alter cellular architecture (Figure 2.6). 
 
No significant difference in the average number of calretinin and 
parvalbumin positive neurons in CA1 and CA3 following exposure to blasts 
The average number of calretinin and parvalbumin immunoreactive cells was not 
significantly affected following mild blasts. However, there were a number of 
noteworthy trends.  
There was a slight increase in the average number of calretinin positive cells 
in CA1 48 hours following a single blast (Figure 2.7 B). Yet in CA3 there was a 
noticeable decrease in calretinin positive cells 48 hours following 3 blasts relative 
to the pooled shams and the other post blast survivals (48 hours following single 
and repeated blasts and one month following three blasts)  (Figure 2.8 B). 
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Interestingly, although the average number of parvalbumin positive cells in CA1 
was the lowest one month following a single blast exposure, it most closely 
resembled the mean average of the pooled shams (Figure 2.9 B). Parvalbumin 
positive cells were noticeably reduced one month following a single blast in CA3 in 
comparison to the other recovery time points (48 hours following single and 
repeated blasts and one month following three blasts) as well as pooled shams 
(Figure 2.10 B).  
The trends reported here indicate not only a differential effect that depends 
on the interneuronal cell type examined, but also the hippocampal sub-region and 
the recovery time point post blast (Figures 2.7 – 2.10). 
 
Densities of calretinin and parvalbumin positive processes in the inner 
molecular layer of the dentate gyrus unchanged following blasts 
Quantitative evaluation of immunostaining was used to determine whether 
exposure to blast affected synaptic processes within this region. The overlapping 
vertical averages of calretinin immunoreactivity in sham and blast exposed animals 
following a single insult (Figure 2.11 B, C) indicated that an isolated exposure did 
not significantly alter the density of calretinin positive processes. Although not as 
striking, the average density of parvalbumin positive processes one month 
following exposure to a single blast was slightly lower than sham (Figure 2.12, D).  
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It has not been established to what extent the observed increases or 
decreases are beneficial or detrimental. In the context of this study, there was no 
positive staining observed for markers implicated in cell death (caspase-3, 
FluoroJade C), therefore the functional implications of the trends reported remain 
unknown. 
 
Percent area of GFAP positive astrocytes significantly affected 48 hours 
following single and repeated exposure to blasts 
To evaluate whether structural differences in astrocytes were present, antisera 
against GFAP was used. Overall, GFAP labeled astrocytes were found throughout 
all hippocampal sub-regions with the lowest density in the pyramidal and granule 
cell layers matching published reports (Shimada et al., 1992; Jinno et al., 2007). 
The stratum lacunosm moleculare showed the strongest GFAP labeling of all 
hippocampal sub-regions (Figures 2.13 and 2.17) and was thus quantitatively 
compared between sham and blast exposed animals.  
Acute recovery (48 hours) to a single blast (n=3) resulted in a significant 
increase in the average percent area of GFAP relative to pooled shams (Figure 
2.13). In contrast, one month following exposure to a single blast a decrease was 
observed relative to pooled shams. Acute recovery to three consecutive blasts 
(n=3) showed a significant reduction in average percent area, similar to the blast 
exposed animals that recovered for one month after a single blast. However, one 
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month following three blasts (n=4) there was a slight increase compared to sham 
(Figure 2.13). 
 
Hypertrophic microglia present acutely following blast 
Iba1 was used to label and classify microglia based on established criteria (Jinno 
et al., 2007). There were significantly more hypertrophic Iba1 positive cells 
following acute recovery (48 hours) to single and repeated blasts (Figures 2.14–
2.17). The amount of hypertrophic cells was restricted to the outer molecular layer 
of the dentate gyrus (Figure 2.16). No hypertrophic cells were detected one month 
following either a single or repeated blast (Figure 2.15). Furthermore, no 
differences were found in the average number of Iba1 positive cells across all 
recovery time points examined (data not included). The morphological differences 
in Iba1 positive cells present in sham versus blast exposed animals suggest that 
the microglia present locally, particularly following acute recovery where 
hypertrophic phenotypes were observed, were likely responding to the effect of 
blast within the microenvironment rather than migration of microglia. 
As discussed in Chapter 1, Iba1 positive cells can assume a broad spectrum 
of morphologies from the dynamic ramified to the phagocytic amoeboid (Figure 
1.4), although subtle and widely varied intermediate morphologies are prevalent 
(Karperien et al., 2013). Variations in morphology are contextual, based on signals 
present in the microenvironment.  In an effort to identify potential factors 
45 
 
 
influencing Iba1 positive cells, immunocytochemistry was used to label several 
mediators such as tumor necrosis factor alpha, interleukin-1, and interleukin-6, 
however staining results were negative for all mediators probed (data not 
included).  
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Figure 2.6. Cytoarchitecture unaffected following acute and chronic recovery to a 
single or repeated blast(s). Low magnification of thionin staining in the 
hippocampus in sham and blast animals. CA1 = cornu ammonis 1. CA3 = cornu 
ammonis 3. DG = dentate gyrus. Scale bar = 200 µm. 
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Figure 2.7. Average cell count of calretinin positive cells in CA1 unchanged 
following blast. (A) Representative calretinin immunostaining, scale bar = 500 µm. 
(B) Blast exposed animals (n=3 for single 48 hours, single one month, triple 48 
hours; n=4 for triple one month) compared to pooled averages from sham animals 
(n=10) showed no significant difference in the average number of calretinin 
positive cells following blast. Error bars represent SD. CA1 = cornu ammonis 1. 
CR = calretinin.  
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Figure 2.8. Average cell count of calretinin positive cells in CA3 unchanged 
following blast. (A) Representative calretinin immunostaining, scale bar = 500 µm. 
(B)  Blast exposed animals (n=3 for single 48 hours, single one month, triple 48 
hours; n=4 for triple one month) compared to pooled averages from sham animals 
(n=10) showed no significant difference in the average number of calretinin 
positive cells following blast. Error bars represent SD. CA3 = cornu ammonis 3. CR 
= calretinin.  
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Figure 2.9. Average cell count of parvalbumin positive cells in CA1 unchanged 
following blast (A) Representative parvalbumin immunostaining, scale bar = 500 
µm. (B) Blast exposed animals (n=3 for single 48 hours, single one month, triple 
48 hours; n=4 for triple one month) compared to pooled averages from sham 
animals (n=10) showed no significant difference in the average number of 
parvalbumin positive cells following blast. Error bars represent SD. CA1 = cornu 
ammonis 1. PV = parvalbumin.  
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Figure 2.10. Average cell count of parvalbumin positive cells in CA3 unchanged 
following blast (A) Representative parvalbumin immunostaining, scale bar = 500 
µm. (B) Blast exposed animals (n=3 for single 48 hours, single one month, triple 
48 hours; n=4 for triple one month) compared to pooled averages from sham 
animals (n=10) showed no significant difference in the average number of 
parvalbumin positive cells following blast. Error bars represent SD. CA3 = cornu 
ammonis 3. PV = parvalbumin.  
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Figure 2.11. Density of calretinin positive processes in the inner molecular layer 
of the dentate gyrus remain unchanged following blast. (A) Representative CR 
positive immunostaining in the hippocampus, scale bar = 100 µm. Black box 
represents the ROI containing the GCL and IML. Vertical averages of CR positive 
processes in the IML shows no significant difference 48 hours following a single 
blast (sham n=2; blast n=3) (B), one month following a single blast (sham n=2; 
blast n=3) (C), and 48 hours (sham n=4; blast n=4) and one month (sham n=2; 
blast n=4) following triple blasts (D and E, respectively).  A. U. = arbitrary units. CR 
= calretinin. GCL = granule cell layer. IML = inner molecular layer. 
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Figure 2.12. (A) Representative parvalbumin immunostaining in the hippocampus, scale bar = 100 µm. Dashed black 
box indicates the general region of hippocampus analyzed. (B) Zoom of the dashed black box in (A). White rectangle 
represents an example ROI sampled within the IML, scale bar = 20 µm. Density of PV positive processes did not 
differ significantly 48 hours following a single blast (sham n=2; blast n=3) (C), one month following a single blast 
(sham n=2; blast n=3) (D), and 48 hours (sham n=4; blast n=4) and one month (sham n=2; blast n=4) following triple 
blasts (E and F, respectively).   Error bars (C-F) represent SEM. A. U. = arbitrary units. CA1 = cornu ammonis 1. CA3 
= cornu ammonis 3. IML = inner molecular layer. PV = parvalbumin. ROI = region of interest. SEM = standard error 
of the mean. 
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Figure 2.13.  The percent area occupied by GFAP in the stratum lacunosum moleculare is significantly altered 
relative to sham acutely following blast. (A) Low magnification image of GFAP positive staining in the hippocampus, 
scale bar = 250µm. (B) Relative to pooled shams, a significant increase in the percent area occupied by GFAP was 
present 48 hours following exposure to a single blast (n=3) that decreased one month (n=3) and was significantly 
reduced 48 hours following three blasts (n=3) and increased one month after three blasts (n=4). Error bars represent 
SD. CA1 = cornu ammonis 1. CA3 = cornu ammonis 3. DG = dentate gyrus. GFAP = glial fibrillary acidic protein. SLM 
= stratum lacunosm moleculare.  
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Figure 2.14. Hypertrophic microglia were restricted to the outer molecular layer of the dentate gyrus 48 hours 
following exposure to a single blast. Low magnification of Iba-1 immunostaining in a representative sham (left), scale 
bar = 250 µm. Inset reveals a ramified cell with thin, ramified processes, scale bar = 20 µm. In contrast, a low 
magnification image from a representative blast exposed animal (right) shows hypertrophic microglia limited to the 
OML. Inset reveals striking hypertrophic morphology of Iba-1 labeled cells. CA1 = cornu ammonis 1. CA3 = cornu 
ammonis 3. DG = dentate gyrus. Iba-1 = ionized calcium binding adapter molecule-1. OML = outer molecular layer.  
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Figure 2.15. Hypertrophic microglia are restricted to the outer molecular layer of the dentate gyrus acutely following 
mild blast(s). CA1 = cornu ammonis 1. CA3 = cornu ammonis 3. DG = dentate gyrus. Iba-1 = ionized calcium binding 
adapter molecule-1. Scale bar = 250 µm. 
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Figure 2.16.  Significantly more hypertrophic microglia present in the outer molecular of the dentate gyrus 48 hours 
following blast(s) relative to sham. Average count of Iba-1 positive cells based on morphology (sham, n=5; single 48 
hours blast n=3 triple 48 hours n = 4). Asterisks denote statistical significance between sham and both blast groups 
(p<0.05). Error bars represent SD. Schematics of microglia morphologies modified from Karperien et al., 2013.  Iba-
1 = ionized calcium binding adapter molecule-1.  
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Figure 2.17. Mouse model of mild direct cranial blast reveals a region specific glial response in the hippocampus 
following acute recovery. Representative low magnification images of the mouse hippocampus. (Left) Dashed lines 
around the dentate gyrus delineate the outer molecular layer where hypertrophic microglia labeled with Iba-1 are 
prevalent. (Right) The region enclosed by dashed lines delineate the stratum lacunosm moleculare, where the GFAP 
immunoreactivity is strongest. CA1 = cornu ammonis 1. CA3 = cornu ammonis 3. DG = dentate gyrus. GFAP = glial 
fibrillary acidic protein. Iba-1 = ionized calcium binding adapter molecule-1. OML = outer molecular layer. SLM = 
stratum lacunosm moleculare. Scale bar = 250 µm. 
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DISCUSSION 
The first goal of this study was to evaluate whether exposure to single or repeated 
blasts altered two non-overlapping populations of interneurons containing 
calretinin or parvalbumin. The second objective was to identify the presence and 
extent of any activation of astrocytes and microglia within the hippocampus. The 
studies were performed following acute (48 hours) and chronic (one month) 
recovery from a single blast or three repetitive blasts spaced 24 hours apart in the 
absence of anesthetics. 
A major limitation of this work is that immunocytochemistry can only convey 
static information regarding dynamic cellular processes. Because of this, it cannot 
be known if the interneurons examined were reversibly altered between the time 
points examined. This is an important limitation to be aware of because the 
localization of calcium-binding proteins can reversibly change spatially and 
temporally (Johansen et al., 1990). The non-stereological approach used for cell 
counting limits the rigor of the results obtained, although there are quantitative 
studies (Lawson et al., 1990; Savchenko et al., 2000) published without the use of 
stereological assessments. In spite of the aforementioned disadvantages, what 
can be concluded from the immunocytochemical evaluations presented here is a 
general overview regarding structural alterations following mild blast 
overpressures, a model that is not routinely used despite its clinical relevance.  
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Immunocytochemical status of calretinin and parvalbumin following blast 
Hippocampal interneurons can be divided into three categories—perisomatic, 
dendritic, interneuronal—as defined, in part, by the spatial organization of their 
synaptic outputs (Somogyi and Klausberger, 2005; Toth and Magloczky, 2014). 
Calretinin positive neurons are reported to synapse onto the dendrites of other 
interneurons in addition to principle cell somata in the rat hippocampus (Gulyas et 
al., 1996). Parvalbumin has been reported to synapse perisomatically onto 
principle cells (Caliskan et al., 2016). The presence of calretinin and parvalbumin 
throughout each hippocampal sub-field allows inferences to be made regarding 
the effect of blast on these distinct interneuron populations. 
 In spite of the aforementioned limitations, the results of this study are similar 
to reports documenting histochemical changes in the expression of other calcium-
binding proteins. One study evaluating short-term changes in parvalbumin 
immunoreactivity following cerebral ischemia in hippocampi of rats revealed a 
delayed decrease that was reversible, despite lack of detectable changes two days 
following insult (Johansen et al., 1990). It was hypothesized that reduced 
parvalbumin immunoreactivity could be the result of reduced synthesis, increased 
degradation, as well as changes in the amount of calcium ions present in the 
cytoplasm.  
Selective sparing of interneurons containing calcium-binding proteins 
following injury have been reported previously, however spared cell populations 
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have been shown to exhibit morphologies indicative of degeneration in human 
cases of epilepsy (Toth and Magloczky, 2014). Although the morphological 
features of parvalbumin and calretinin positive neurons were not assessed in 
detail, in general there were no obvious differences in blast versus sham.  
However, the slight differences in the density of dendritic arborizations suggest 
some differences in the intracellular localization of the antigens or anatomical 
alterations within the arborizations.  
Overall there are certain inconsistencies in the literature regarding the 
status of calretinin and parvalbumin. For example, one group reported greater 
vulnerability of perisomatic versus dendritic interneurons following TBI (Huusko et 
al., 2015), while another group found dendritic interneurons containing the 
neuropeptides somatostatin and neuropeptide-Y to be highly vulnerable (Toth et 
al., 2010). These differences may be due, in part, to the dynamic nature of cellular 
responses and the species under evaluation. Additional factors to consider include 
differences in time points examined and experimental design as several of the 
previously discussed studies focused on epilepsy (Toth and Magloczky, 2014), 
cerebral ischemia (Johansen et al., 1990), and focal TBI resulting from FPI 
(Huusko et al., 2015).  
 
 
 
61 
 
 
Status of astrocytes and microglia following blast exposure 
The complex relationship between astrocytes and microglia in the hippocampus 
has been the focus of several studies (Savchenko et al., 2000; Jinno et al., 2007; 
Pascual et al., 2012). Results of this study demonstrated significant differences in 
the percent areas of GFAP in the stratum lacunosum moleculare and in Iba1 in the 
outer molecular layer of the dentate gyrus.  
GFAP percent coverage in the stratum lacunosum moleculare showed a 
significantly acute increase 48 hours after one blast. However, a dramatic 
decrease at one month following one blast was also present 48 hours following 
three blasts. The combination of blasts directed between bregma and lambda and 
full head mobility could underlie the changes reported in the GFAP 
immunoreactivity in the stratum lacunosum moleculare. There are also several 
physiological explanations to account for the differences the percent area, three of 
which will be highlighted. 
The first plausible explanation relates to the inputs and outputs to the 
stratum lacunosum moleculare. Direct input to the dendrites of pyramidal cells 
within the stratum moleculare is from glutamatergic cells in layer 3 of the entorhinal 
cortex (Maccaferri, 2011) with additional thalamic input from the nucleus reuniens 
(Andersen, 2007). Previously, increases in GFAP within the stratum lacunosum 
moleculare have been documented in an animal model of epilepsy (Dalby et al., 
1995). Increased GFAP immunoreactivity was attributed to the previously reported 
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increased neuronal activity (Steward et al., 1991). Thus the changes observed in 
GFAP at the blast time points, relative to control, in this study could result from 
cellular changes due to blast in distal regions such as the entorhinal cortex.   
The stratum lacunosm moleculare also contains a high density of blood 
vessels and has been reported to possess a high energy metabolism (Shimada et 
al., 1992). Astrocytes have a significant role in maintaining vascular networks that 
supply neurons with glucose from the bloodstream (Lund-Andersen, 1979; 
Pardridge, 1983). In this study, the GFAP immunoreactivity was intensely 
associated with vasculature (Figure 2.5). Thus the second, and perhaps more 
probable, explanation pertains to the effect of blast on vasculature. It is not 
unreasonable that the mild blasts in this study affected the integrity of the vessels 
and/or the astrocytes within this region. A number of TBI and related studies have 
documented the link between astrocytic changes, vascular alterations, oxidative 
changes, and inflammation (Ogundele et al., 2014; Karve et al., 2016). The 
increase in percent area of astrocytes observed 48 hours after a single blast was 
expected and can be readily confirmed by studies reporting elevations in GFAP 
immunoreactivity following injury. One study examined blood brain barrier integrity 
hours (2–6 hours) and days (1–7) following controlled cortical impact (Baskaya et 
al., 1997). Results showed a biphasic response to injury with an increase in 
membrane permeability 24 hours following injury and then again 3 days later 
(Baskaya et al., 1997) similar to a previously reported increase following ischemic 
insult (Hatashita and Hoff, 1990). As it relates to blast-induced injury, one study 
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found evidence of cerebrovascular inflammation and oxidative stress 6 to 24 hours 
following exposure to single and repeated blasts (Abdul-Muneer et al., 2013).  
Third, given the nature of the detection method it is possible there was a 
loss of immunoreactivity due to altered antigenicity. The decreases observed one 
month following a single blast and 48 hours following three blasts were initially 
unexpected. However, review of the literature does show evidence to support a 
decrease in GFAP immunoreactivity following injury. One study examining the 
effect of lateral fluid percussion injury reported a significant loss of GFAP 30 
minutes following injury that remained progressive up to 24 hours (Zhao et al., 
2003). It was hypothesized that diminished immunoreactivity was due to 
dismemberment of intermediate filaments present in astrocytes due to alterations 
in protein function. Another study attributed diminished GFAP labeled astrocytes 
to an increase in fibroblast growth factor signaling (Kang and Song, 2010). While 
the structural variation in GFAP following acute (48 hour) and chronic (one month) 
recovery to the blast paradigm in this study are of interest and have been 
supported in the literature, the interpretation from this work is limited because the 
molecular identity of the glial phenotypes are unknown. As indicated in Chapter 1, 
astrocytes have a role in neurotrophic and cytotoxic responses. The heterogeneity 
of astrocytic responses following insults has motivated the use of multiple assays 
to fully characterize molecular changes in glia (Anderson et al., 2014) and would 
be of great benefit in the present study.    
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Similar to astrocytes, microglia are commonly documented in pathological 
conditions however, their role is also not a simple dichotomy. Under a variety of 
conditions microglia can undergo subtle or dramatic changes in morphology (Karve 
et al., 2016). As discussed in Chapter 1, microglia can infer beneficial 
neuroprotective effects (M2 microglia) or promote injury cascades (M1 microglia). 
It is unclear whether the structural changes observed at the 48-hour time point in 
this study are beneficial or detrimental. It could be that the hypertrophic cells in the 
outer molecular layer represent a lesion of microglia that is a newly formed scar or 
presence of a resolving lesion. Regardless, the spatially restricted hypertrophic 
phenotype in the outer molecular layer of the dentate gyrus suggests that this 
region could be susceptible to blast-related insults.  
In animal models of TBI, hypertrophic microglia are either diffuse throughout 
the hippocampus, or diffuse within a specific sub-field. Interestingly, a mouse 
model of Alzheimer’s disease documented amyloid beta pathology that was 
restricted to the outer molecular layer of the dentate gyrus in transgenic mice 
(Schenk et al., 1999).  However, no hypothesis to account for the regional 
susceptibility to pathology was provided. Indication of a similarly striking spatially 
restricted glial response was lacking. In spite of this, based on established reports 
of microglial dynamics (Schwartz et al., 2006; Karperien et al., 2013; Karve et al., 
2016), it is highly unlikely that the observed hypertrophy is spurious. What is most 
probable is the detection of a region specific microglial response that may be 
transient. The outer molecular layer of the dentate gyrus receives inputs from the 
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entorhinal cortex (Forster et al., 2006). Thus, similar to the unique differences in 
GFAP immunoreactivity, the neuronal activity within this specific hippocampal sub-
region, the complexities of microglial interactions with adjacent neurons and glia 
could contribute to the observed phenotypes. Use of assays to identify changes in 
levels of relevant ions/neurotransmitters or gene expression, which are more 
sensitive than the histological method employed here, could provide greater insight 
regarding subtle changes following exposure to mild blasts. The benefit in a more 
detail characterization of the functional phenotypes (cytotoxic M1 versus 
reparative M2) would aid insight into the cellular response within the hippocampus 
to mild blast and, potentially, how such changes compare with other models of TBI. 
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CHAPTER 3 
Immunocytochemical examination of glial morphologies following exposures to 
mild repetitive blasts in the mouse brain and retina 
ABSTRACT 
As an accessible part of the central nervous system (CNS), the retina has become 
an integral focus in evaluating visual pathologies following blast injury. Recognition 
of the retina’s potential to extrapolate central damage is due, in part, to the 
similarities in brain and retinal pathology following other CNS insults. The goal of 
this study was to evaluate whether glial morphologies in the retina were similar to 
central visual pathways (lateral geniculate nucleus, superior colliculus, and visual 
cortex) in a mouse model of mild repetitive blast injury. The time points examined 
were 48 hours and one month following multiple blasts. Results demonstrated no 
morphological alterations in astrocytes or microglia following exposures. The 
absence of structural alterations in glia at the time points examined could be 
attributed to the rapid and reversible properties of glia. Additional efforts to identify 
potential functional alterations, in absence of anatomical changes, are warranted.  
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INTRODUCTION 
 
Vertebrate visual system 
Despite its peripheral location, the retina originates from the developing 
diencephalon and is thus part of the central nervous system. The capture of light 
by photosensitive cells within the retina is the first stage of visual processing. The 
retina is stratified by the somata of the photoreceptors (rods and cones), bipolar 
cells, horizontal cells, amacrine cells, ganglion cells and the plexiform layers 
containing the synaptic contacts of each cell type (Hoon et al., 2014). In addition 
to retinal neurons there are three glial cell types in the retina, Müller cells, 
astrocytes, and microglia. Müller cells span the width of the retina and guide 
neuronal development. In addition, Müller cells provide structural support (Vecino 
et al., 2016). Astrocytes extend end feet that help form the blood retinal barrier and 
are prevalent within the inner retina, most commonly associated with ganglion cell 
axons (Seoane et al., 1999). Microglia are dynamic sentinel cells scattered 
throughout the retinal layers that continuously survey the microenvironment and 
phagocytose debris (Karlstetter et al., 2015; Horstmann et al., 2016).   
Ganglion cell axons form the major output from the retina to central brain 
regions responsible for higher order visual processing (London et al., 2013). 
Although the retina projects to over 30 different brain regions (Morin and 
Studholme, 2014), the dorsal lateral geniculate nucleus, superior colliculus, and 
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visual cortex are the most widely documented central regions involved in visual 
processing and were the regions evaluated in this study.  
The dorsal lateral geniculate nucleus (DLG) is the main thalamic relay in 
mammals for visual information from the retina.  Approximately 70–80% of neurons 
within the DLG process input from retinal ganglion cells before projecting 
information to regions responsible for behaviors such as pupil dilation and reflexive 
eye movements (Huberman and Niell, 2011; Leist et al., 2016). The primary visual 
cortex is an essential cortical region that receives direct input from the DLG before 
projecting to visual association areas responsible for the perception and 
recognition of complex visual features such as motion and depth (Huberman and 
Niell, 2011). 
In addition to the DLG, the superior colliculus (SC) is another major recipient 
of information from retinal ganglion cells. The SC is a mammalian midbrain region 
that is the equivalent of the optic tectum in non-mammalian vertebrates (Kandel, 
2013). The SC is recognized for its essential role in regulating head and eye 
movement in response to visual stimuli (Byun et al., 2016), although it is also 
implicated in an array of species-specific behaviors such as limb direction toward 
targets and threat perception (May, 2006). Although the SC is highly laminated it 
is often simply divided into superficial and intermediate layers based on structural 
and functional distinctions (Ghose et al., 2014; Byun et al., 2016). The superficial 
layers receive direct visual input from the retina and are believed to have a 
significant role that is exclusive to visual integration (Langer and Lund, 1974). By 
69 
 
 
contrast, deeper layers are associated with integration of several sensory and 
motor systems (Sparks and Hartwich-Young, 1989). 
 
Visual system pathology following blast 
Blast injuries can impair vision at different stages of the afferent visual pathway 
from the retina to higher visual centers in the brain, or even the efferent pathways 
(Cockerham et al., 2009). While ocular trauma in the form of ruptured globes and 
penetrating injuries have been documented, less overt eye injuries may pose an 
increasing cause for concern because visual impairments in the absence of 
physical injury to the eye have also been reported (Lemke et al., 2013). Such 
impairments include problems with accommodation, saccades and pursuits, 
vergence, integrity of the visual field, and photophobia (Kapoor and Ciuffreda, 
2002; Suh et al., 2006; Goodrich et al., 2007; Stelmack et al., 2009; Alvarez et al., 
2012; Bulson et al., 2012; Capo-Aponte et al., 2012; Cockerham et al., 2013; 
Walsh et al., 2015) which suggests that visual system pathology has contributions 
from the brain, as well as the eye.  
Reports of similar brain and retinal pathology following blast injury have 
motivated efforts to examine the utility of the retina as a surrogate for central 
damage. Ganglion cell damage in rodents following blast is similar to that seen in 
humans, indicating that the rodent visual system can provide information that may 
eventually be useful diagnostically and therapeutically (Wang et al., 2014). A 
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widely cited animal study conducted by Petras et al. (1997) compared brain and 
retina pathology following a range of sub-lethal blast overpressures delivered 
perpendicularly to the side of rats using a shock tube. In accordance with other 
animal studies supporting similar pathologies in the brain and retina following blast, 
axonal degeneration in the optic nerve, superior colliculus, diencephalon and 
thalamus mirrored retinal injuries (Petras et al., 1997; Mohan et al., 2013; Bricker-
Anthony et al., 2014; Dutca et al., 2014).  Similarly, work from Koliatsos et al. 
(2011) that comprehensively documented pathology in the retina and brain of mice 
following blast exposure found axonal degeneration in retinal ganglion cells 
(RGCs) and axonal tracts in brain including the optic and corticospinal tracts.  
 
Study objectives 
Although fiber degeneration receives considerable attention, due to the extensive 
projections from the retina to thalamus, midbrain and cortex, less is known about 
the status of glia throughout the visual pathway following blast. Therefore the goals 
of this study were to immunocytochemically identify whether gliosis was present in 
the retina, DLG, SC, and visual cortex (Figure 3.1) following exposure to mild 
repetitive blasts. 
 
 
71 
 
 
 
 
 
Figure 3.1. General schematic of the rodent visual pathway from retina to selected 
brain regions involved in visual processing. DLG = dorsal lateral geniculate SC = 
superior colliculus VC = visual cortex. Schematic modified from Do and Yau, 2010.
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METHODS  
Blast Wave Measurements and Calibration 
A precision dynamic high frequency piezoelectric pressure transducer (Model: 
113B21 High Frequency ICP® pressure sensor, PCB Piezotronics, Inc., Depew, 
New York) was used to calibrate blast waves produced by the Cranium Only Blast 
Injury Apparatus (COBIA), (Figure 3.2A). The sensor was positioned where the 
head of the mouse would be inside the apparatus. A constant current supply 
(Model 5421, Columbia Research Laboratories, Inc., Woodlyn, PA) provided 
power to the transducer. Outputs were digitized using an analog to digital converter 
(Analog Devices, ADAS3022) before saving waveforms for offline analysis. The 
average blast overpressure was 1,034 kPa (Figure 3.2B). 
 
Blast procedure 
All procedures were approved by the Institutional Animal Care and Use Committee 
at Boston University. 
1. Adult C57BL/6 mice (2–6 months) were acclimated for 72 hours upon arrival to 
the Boston University animal facility where they were ear tagged while 
anesthetized with isofluorane.  Mice were then acclimated for five days prior to 
experimentation in order to eliminate potential confounds from the presence of 
anesthesia. 
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2. The COBIA was used to generate blast overpressures as described and 
characterized previously (Kuehn et al., 2011). The central component of the 
COBIA was a .22 caliber, single-shot, powder-actuated tool (Ramset RS22; ITW 
Ramset, Glendale Heights, IL) modified by removing the piston that normally drove 
the fastener, causing it to function like a firearm allowing the blast wave to 
propagate un-dampened through the barrel. The tool was held vertically using a 
custom-fabricated stand, which also ensured its safe use. The blast was directed 
downwards into a blast dissipation chamber (BDC) that interfaced snugly with the 
muzzle of the tool (Figure 3.2A). The BDC was fabricated from polyvinyl chloride 
piping that directly delivered the blast overpressures onto the dorsal surface of the 
head.  The blast wave was generated by firing a .22 caliber crimped brass cartridge 
(power hammer loads power level 4, yellow color coding, with 179 ± 5mg of 
smokeless powder). 
All animals were weighed prior to experimental use. A mouse cylindrical 
restrainer (Stoelting Co. Wood Dale, IL) was used to immobilize animals. Custom 
paper cones were fitted and wetted around the head to prevent potential 
quaternary damage from gunpowder during blasts. Once restrained, animals were 
inserted with the cranium positioned two centimeters from the opening of the BDC. 
Blasts were directed between bregma and lambda. Sham animals represent mice 
treated identically to the blast exposed mice with the exception of exposure to 
blast.  
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Glial responses were evaluated 48 hours and one month following exposure 
to three consecutive blasts spaced 24 hours apart (Figure 3.2C). 
 
Tissue Preparation  
Following recovery from repeated blasts, mice were deeply anesthetized with 
isofluorane (Butler Schein) prior to perfusion with heparinized saline (0.9% sodium 
chloride in distilled water) followed by 4% paraformaldehyde in 0.1 M phosphate 
buffer (PB, pH 7.4). Immediately after perfusion the mice were decapitated, their 
brains were harvested intact, and eyecups were created from each enucleated eye 
by cutting along the corneo-sclera divide to allow removal of the cornea, lens, and 
vitreous. All tissues were immersed in 4% paraformaldehyde in PB overnight at 
4˚C.  
After immersion fixation the eyecups and intact brains were cryoprotected 
in PB containing sucrose concentrations gradually increased from 5% to 30% 
overnight at 4˚C.  Brains were dissected from bregma -0.94mm to -2.92mm using 
an adult mouse brain slicer matrix (BSMAS001-1, Zivic Instruments, Pittsburgh, 
PA). Serial coronal sections (40 µm) were obtained using a freezing sliding 
microtome (Reichert Jung). All cryoprotected tissues were stored at -20˚C in 
cryoprotectant (30% sucrose (Sigma S0389), 30% ethylene glycol (Fisher BP230-
1), 1% polyvinylpyrrolidone (BP431-500) in Tris-buffered saline pH 7.6 (0.4M 
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Trizma HCl, Sigma T-3253, 0.01M Trizma base, Sigma T-1503, 0.15M Sodium 
Chloride, Fisher BP358-212) prior to immunostaining. 
 
Immunocytochemistry  
Retinal Wholemounts 
Eyecups were washed with several changes of PB for one week to remove residual 
cryoprotectant. To thoroughly document glial morphology retinal wholemounts 
were created based on modifications to previously published protocols (Claybon 
and Bishop, 2011; Ivanova et al., 2013; Tual-Chalot et al., 2013). In short, retinas 
were isolated intact following four perpendicular cuts from the peripheral retina 
half-way toward the optic nerve head. Wholemounts were washed in PB for two 
days prior to quenching of endogenous peroxidase (3% hydrogen peroxide in PB) 
free floating on a rotator for 30 minutes at room temperature. Non-specific labeling 
was blocked using 5% normal donkey serum (Jackson ImmunoResearch 
Laboratory, Inc. West Grove, PA) diluted in 0.5% Triton-X 100 in PB (PBTx, Sigma) 
overnight at 4°C on rotator. Following blocking, the wholemounts were individually 
incubated in either mouse anti-glial fibrillary acidic protein (GFAP 1:250, Clone No. 
N206 A/8, UC Davis/NIH NeuroMab Facility Cat# 75-240, RRID:AB_10672299) or 
rabbit anti-Iba1 (1:1000, Wako, Catalog No. 019-19741), for 72 hours at 4°C on a 
rotator. 
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Brain Slices  
Brain slices (bregma -3.08 to -3.40mm) containing the dorsal lateral geniculate 
nucleus, visual cortex, and the superior colliculus (Figure 3.3) were selected 
(Franklin and Paxinos, 2008). Free floating sections were washed extensively in 
PB to remove residual cryoprotectant and then mounted and air-dried onto 
Colorfrost Plus subbed slides (ThermoFisher Scientific, Waltham, MA). Following 
rehydration in PB the slices were incubated in 95°C sodium citrate buffer (10mM 
sodium citrate, 0.05% Tween 20, pH 6.0) for twenty minutes. Following antigen 
retrieval slices were allowed to cool to room temperature and washed several 
times in PB. Endogenous peroxidase was quenched using 3% hydrogen peroxide 
before incubation in 5% normal donkey serum (Jackson ImmunoResearch 
Laboratory, Inc. West Grove, PA) diluted in 0.3% PBTx for one hour at room 
temperature. Following blocking, slices were incubated overnight at 4˚C in primary 
antisera directed against either GFAP (GFAP 1:250, Clone No. N206 A/8, UC 
Davis/NIH NeuroMab Facility Cat# 75-240, RRID:AB_10672299) or Iba-1 (1:1000, 
Wako, Catalog No. 019-19741).  
The specificity of these antisera in mice has been previously demonstrated 
(Ramirez et al., 2010; Karlstetter et al., 2015). For retinal wholemounts and coronal 
brain slices, some tissues were incubated without primary antisera to ensure that 
the signal observed was specific to the antigens probed.   
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Chromogenic detection   
After incubation in primary antisera, tissues were incubated in the appropriate 
biotinylated secondary antisera, either donkey anti-mouse (Jackson Immuno 
Research, Catalog No. 715-065-137) or donkey anti-rabbit (Jackson Immuno 
Research, catalog No. 711-065-152) diluted 1:500 in 0.3% PBTx (brains) or 0.5% 
PBTx (wholemounts) for one hour at room temperature. Following incubation in 
biotinylated secondary antisera, tissues were incubated for 90 minutes in 
Neutravidin conjugated to horseradish peroxidase (diluted 1:250 in 0.3% PBTx; 
ThermoFisher Scientific).  Chromogenic detection was carried out using Metal-
Enhanced 3’3’-diaminobenzidine (DAB) substrate (diluted 1:10 in stable peroxide 
buffer, Pierce Chemical Company, Rockford IL). DAB development was stopped 
by immersion in several changes of PB. Brain slices were rinsed in distilled water 
and coverslipped in Gelvatol (10% polyvinyl alcohol, Sigma P8136, 20% glycerol, 
Sigma G-9012, 0.02% sodium azide, Fisher s-227-100, 0.2M Tris, Amresco 0497, 
pH 8.5) prior to imaging. Retinal wholemounts were dried onto Colorfrost slides 
and coverslipped using Gelvatol. 
 
Imaging  
Brain slices and retinal wholemounts were imaged on a Nikon Eclipse motorized 
microscope (Nikon Instruments, Inc.) at 4x, 10x and 20x. 
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Analysis  
Retinal Wholemounts 
ImageJ software (U.S. National Institutes of Health, Bethesda, Maryland, USA) 
was used for quantitative analysis. Regions of interest (ROI) delineating the 
central, mid-central, and peripheral retina were created in Image J and applied to 
the grayscale images. The location of the optic nerve was used to center the ROIs 
(Figure 3.4). The size of each ROI was matched across all wholemounts captured 
at 4x. 
 Four RGB (red, green, blue) multi-channel images within each ROI were 
obtained at 20x. All images were converted to single wavelength channel images. 
The channel with the greatest signal to noise contrast (blue) was selected and 
used across all groups. Two cells within each image were selected for analyses.  
All single channel (grayscale) images were made binary using a threshold overlay. 
An ROI large enough to enclose a single cell was used for all analyses. The area 
fraction, defined as the percent coverage (percent area) of immunoreactivity within 
each ROI, was obtained for each binary image using the area fraction selection 
from the ImageJ "Measure” feature. It was expected that hypertrophy, due to glial 
activation, would be reflected as a greater percent area because the cells would 
be larger in size and therefore occupy a greater percentage of the ROI.  
Values for percent area were obtained for each cell within each ROI. 
Results were averaged by region (central, mid-central, peripheral) for every animal 
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and then averaged by condition (sham versus blast). To determine if significant 
differences in the percent areas of sham and blast exposed animals were present 
across central, mid-central, and peripheral retinas, a two-way analysis of variance 
was used (SPSS v24, IBM Corp.). Significance was set at p<0.05.  
 
Brain slices 
Similar to retinal wholemounts, RGB images were obtained and converted to single 
channel images for all subsequent analyses. 
Regionally matched ROIs were used to determine percent area following 
the same procedure outlined previously for retinal wholemounts. An analysis of 
variance (ANOVA), was used (SPSS v24, IBM Corp.) to determine if significant 
differences in the percent area of GFAP labeled astrocytes were present in acute 
versus chronic recovery post blasts. Significance was set at p<0.05. 
 To determine if differences in both the number and morphology of Iba-1 
labeled microglia existed among sham and blast exposed mice, manual counts 
were performed by an observer blinded to condition. Counts of Iba-1 positive cells 
were averaged for each animal and then averaged by group. Iba-1 cells were 
categorized in based on three broad morphological groups: ramified, hypertrophic, 
and amoeboid (Karperien et al., 2013). A two-way analysis of variance (ANOVA) 
was used (SPSS v24, IBM Corp.) to establish whether differences in the average 
number of cells based on morphology was significant (p<0.05).
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Figure 3.2. (A) The Cranium Only Blast Injury Apparatus (COBIA) used to 
generate blast overpressures. (B) Pressure waveform produced by the COBIA 
revealing maximum overpressure of 1,034 kPa. (C) Repetitive blast paradigm of 
acute (48 hours) and chronic (one month) recovery following three consecutive 
blasts with 24 hour latencies. BDC = blast dissipation chamber. 
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Figure 3.3. General schematic of selected brain regions involved in visual 
processing. Dashed vertical lines and corresponding numbers represent coronal 
brain slices containing regions of interest (Left, Nissl stain; Right, Corresponding 
line drawing). DLG = dorsal lateral geniculate SC = superior colliculus VC = visual 
cortex. Nissl stained coronal images modified from Franklin and Paxinos, 2008.
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Figure 3.4. Delineation of central, mid-central, and peripheral retina based on 
location of the optic nerve. 
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Figure 3.5. Evaluation of the percent area occupied by GFAP. (A) Single channel (grayscale) image of GFAP staining 
in a retinal wholemount, scale bar = 100µm. (B) Representative threshold overlay applied to GFAP labeling present 
in grayscale image in (A). (C) Resulting binary image. GFAP = glial fibrillary acidic protein. 
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RESULTS 
No hypertrophic glia were present in the retina following multiple blasts 
Astrocytes with GFAP immunoreactivity showed no indication of hypertrophy 
throughout the retina 48 hours and one month following three consecutive blasts 
(Figures 3.6 and 3.7). Quantitative analyses were not performed to assess whether 
differences were present in astrocytes and microglia. However during microscopic 
observation, all of the cells (somata and processes) had the same appearance. 
Processes from all of the GFAP labeled cells within the central, mid-central, and 
peripheral retina possessed a thin ramified appearance (Figures 3.6 and 3.7). 
Similarly, there were no differences in the percent area of individual Iba-1 positive 
cells from sham and blast exposed animals (Figure 3.8). Similar to astrocytes, the 
processes of Iba-1 cells revealed no hypertrophy. 
 
No structural alterations in DLG following repeated blasts 
The Iba1 positive microglia that tiled the DLG in a non-overlapping fashion 
contained thin ramified processes with no difference in the average number of Iba1 
positive cells present, although there was considerable variability in the average 
number of Iba1 positive cells in animals allowed to recover 48 hours following three 
blasts (Figure 3.9). Minimal GFAP immunostaining was present within the DLG for 
both sham and blast animals (data not included).  
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No significant gliosis present in the SC and Visual cortex following repeated 
blasts 
A slight increase in the percent area occupied by GFAP was observed 48 hours 
following repeated blast exposure in both the SC and visual cortex relative to 
control (Figures 3.10 and 3.11). The GFAP labeling in the SC at the 48-hour time 
point was diffuse throughout the colliculi whereas in the sham and one month 
recovery the staining was focal (Figure 3.10). Similarly, a slight decrease was 
observed one month following consecutive blasts in both brain regions (Figures 
3.10 A and 3.11 A). It is of note that the superficial layers in the visual cortex had 
the greatest GFAP immunoreactivity (Figure 3.11 B–D). 
 Although not significant, the percent area occupied by GFAP labeled 
astrocytes showed a similar pattern in the SC and visual cortex (Figures 3.10 and 
3.11). Overall there was no change in the average number of microglia present in 
the visual cortex. A small number of hypertrophic cells were observed 48 hours 
following three blasts, however the morphology of most cells were ramified at the 
48 hour time point and all of the cells assessed in the sham groups and one month 
recovery cohort were ramified (Figure 3.12).  Similarly, no hypertrophic cells were 
observed in the SC (data not included). 
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Figure 3.6. There was no difference in the average percent area occupied by 
GFAP labeled astrocytes 48 hours following three consecutive blasts. Error bars 
represent SD (n=3 for each group). Binary images below each bar are 
representative binary images of astrocytes observed within each region of retina 
evaluated (central, mid-central, and peripheral). GFAP = glial fibrillary acidic 
protein. Scale bar = 20µm. 
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Figure 3.7. There was no difference in the average percent area occupied by 
GFAP labeled astrocytes one month following three consecutive blasts. Error bars 
represent SD (n=3 in each group). Binary images below each bar are 
representative binary images of astrocytes analyzed within each region of retina 
evaluated (central, mid-central, and peripheral). GFAP = glial fibrillary acidic 
protein. Scale bar = 20µm. 
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Figure 3.8. There were no hypertrophic microglia in the retina 48 hours following 
repeated blast exposures. Representative microglia morphologies in sham (A) and 
blast exposed mice (B) No difference in the average percent area occupied by Iba-
1 positive microglia (sham n=4, blast n=5), error bars represent SD (C). Iba-1 = 
ionized calcium-binding adapter molecule-1. Scale bar = 30µm. 
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Figure 3.9. Hypertrophic microglia were not observed in the dorsal lateral 
geniculate nucleus following repeated blasts. (A–C) Representative Iba-1 
immunostaining revealing tiled, non-overlapping ramified microglia. (D) There was 
no difference in average counts of Iba1 positive cells (n=3 in each group), error 
bars represent SD. Iba1 = ionized calcium binding adapter molecule-1. Scale bar 
= 100µm. 
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Figure 3.10. GFAP labeled astrocytes in the superior colliculi following exposure 
to repeated blasts. (A) Relative to sham (dashed horizontal line) there was a slight 
increase in the average percent area occupied by astrocytes 48 hours following 
three blasts (n=3) while a slight decrease in the average percent area occupied by 
astrocytes was detected one month (n=3) following repeated blasts. 
Representative sham (B) and blast exposed mice 48 hours (C) and one month (D) 
following three blasts. Error bars represent SD. GFAP = glial fibrillary acidic 
protein. GFAP = glial fibrillary acidic protein. Scale bar = 100 µm. 
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Figure 3.11. GFAP labeled astrocytes in the visual cortex following exposure to 
repeated blasts. (A) Relative to sham (dashed horizontal line), there was an 
increase in the average percent area occupied by astrocytes at 48 hours post 
repeated blast (n=3), while there was a decrease in the average percent area 
occupied by astrocytes at one month (n=3) following repeated exposures. 
Representative sham (B) and blast exposed mice 48 hours (C) and one month (D) 
following three blasts. Error bars represent SD. GFAP = glial fibrillary acidic 
protein. Scale bar = 100 µm.   
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Figure 3.12. There was no significant difference in the average number of Iba-1 
labeled cells in the visual cortex following three consecutive blasts. Hypertrophic 
microglia were largely absent in the visual cortex following three consecutive 
blasts, although a small number of hypertrophic microglia were observed 48 hours 
following three blasts. Iba-1 = ionized calcium binding adapter molecule-1. 
Schematic of microglia morphologies modified from Karperien et al., 2013.  
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DISCUSSION 
The absence of structural alterations detected in glial morphologies at the time 
points evaluated suggests that the regions of the visual system examined—retina, 
DLG, SC, and visual cortex may have been structurally spared from the diffuse 
injury that is common following blast. However, it is possible that transient 
alterations in glial phenotypes occurred along a more acute (less than 48 hours) 
time scale as morphological alterations in glia can be rapid and reversible (Karve 
et al., 2016). In light of this, it is possible that transient hypertrophy in one or both 
of the glial populations could have occurred. The intermediate filament (GFAP) and 
microglial calcium-binding protein (Iba1) are commonly used markers to identify 
injury status. However, use of glial markers to label Müller cells within the retina 
and myelin outside of the retina within the optic nerve and tracts, may reveal the 
existence of alterations in more subtle histopathology following the mild blasts 
used in this study.  
 Alternatively, it may be that the blast overpressures applied onto the dorsal 
surface of the head in this study were too low to produce the visual pathology 
commonly seen following blasts. However, an important consideration is the 
orientation of the animals with respect to blast. Several studies (Mohan et al., 2013; 
Bricker-Anthony et al., 2014; Bricker-Anthony and Rex, 2015; DeMar et al., 2016) 
highlight the importance of blast wave directionality in rodents. For example one 
study (Guley et al., 2016) in mice evaluating visual system deficits found that a 
single blast directed unilaterally onto a small portion of the cranium produced 
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noticeable axonal damage. Another rodent study (DeMar et al., 2016) using 
electroretinograms (ERGs) and histology found retinal pathology to be absent 
when blasts were directed to the front of the head rather than unilaterally (to one 
side of the animal). This finding demonstrates that orientation with respect to the 
direction of blast waves can affect the pathological outcome, which may account 
for the lack of glial alterations in this study.   
 While differences in percent area between control and experimental groups 
are commonly used within the IHC field, this form of analysis cannot adequately 
detect subtle morphological differences. Morphometric studies using Sholl analysis 
in neurons and fractal dimension in microglia (Karperien et al., 2013; Williams et 
al., 2013) have revealed subtle differences in glia from control and experimental 
groups. Regardless, although use of structural changes as a proof of concept in 
injury models is prevalent, functional alterations in the absence of anatomical 
pathology have been reported (Wang et al., 2013) and could be a feature of the 
model employed. While most reports center on neuronal functionality, functional 
assessments of glia using markers to label channels such as glutamate 
transporters (Maguire et al., 1998) could offer additional insight into the potentially 
subtle and transient glial changes following mild blasts. 
The increased motivation to accurately identify and eventually treat TBI-
related pathologies during life has prompted work focused on the evaluation of 
functional integrity within the central nervous system following injury. For example, 
non-invasive assessments of the retina include optical coherence tomography 
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(OCT) (Schuman, 2008; Spaide et al., 2008), which produces high resolution in 
vivo cross-sections of the retinal microstructure, and ERGs which measure the 
electrical activity in the retina following stimulation with light (Gouras, 1970). 
Although OCT, ERGs and their derivatives are used in humans, they have been 
adapted for use in animals and provide critical information on visual system 
integrity. For example, diminished functional integrity of the retina and optic nerves 
following acute and chronic blast exposure in mice, have resulted in significant 
reductions in pattern-electroretinograms (Porciatti, 2007; Azarmina, 2013), a 
modified ERG used to evaluate RGC integrity by summing the depolarization of 
RGCs in response to light stimulation (Mohan et al., 2013). Modifications to non-
invasive techniques such as positron emission tomography (Muzaffar et al., 2013) 
and magnetic resonance imaging, (Townsend et al., 2008) used to assess integrity 
of soft tissue organs such as the brain have been applied to the retina (Cheng et 
al., 2006).  While OCT and ERGs allow valuable insight into retinal function, 
visually evoked potentials (VEP) provide rapid, reproducible, and objective insight 
into overall integrity of afferent visual pathways (Kolappan et al., 2009). VEPs are 
electrical signals produced in the primary visual cortex in response to a time-locked 
visual stimulus (Sokol, 1976; Yadav and Ciuffreda, 2013). The ability of VEPs to 
aid in the cortical evaluation of different deficits in the retina and brain gives it 
considerable advantage in identifying visual impairments that extend beyond the 
retina.  
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CHAPTER 4 
Immunocytochemical evaluation of tau pathology and parvalbumin in visual 
cortices of advanced chronic traumatic encephalopathy in human postmortem 
brains 
 
ABSTRACT 
Chronic traumatic encephalopathy (CTE) is a devastating progressive 
neurodegenerative tauopathy that is widely associated with mild repetitive head 
injury. Although visual deficits are reported in CTE, the primary visual cortex is 
often spared. In this study, immunocytochemistry was used to determine whether 
lateral visual association (extrastriate) areas were susceptible to the tau pathology 
that is common in CTE. In addition, a sub-class of inhibitory interneurons 
containing the calcium-binding protein parvalbumin was assessed using un-biased 
stereology to evaluate a potential cell specific vulnerability. Results showed 
progressive tau pathology in extrastriate cortices that was largely absent from the 
primary visual cortex. No change was observed in the number of parvalbumin 
positive cells. The results of this work provide valuable insight regarding the extent 
of tau pathology in visual association cortices and the potential cell-specific 
resistance despite advanced CTE pathology. 
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INTRODUCTION  
What is chronic traumatic encephalopathy? 
Chronic traumatic encephalopathy (CTE) is a distinct neurodegenerative disorder 
associated with mild repetitive brain injuries (McKee et al., 2013). Historically, CTE 
was first described in 1928 by pathologist Dr. Harrison Martland, who observed the 
late onset of behavioral and cellular pathology in boxers (Martland, 1928). Around 
the time of Martland’s account terms such as ‘punch drunk’, ‘dementia pugilistica’ 
and ‘psychopathic deterioration of pugilists’ were used to describe the outward 
display of CTE symptoms that were associated with boxing (Yi et al., 2013). 
Although early reports of CTE were mainly in boxers, clear evidence to support the 
association of CTE in other sports such as football, hockey, rugby, wrestling, and 
soccer led to the broadly encompassing term ‘progressive traumatic 
encephalopathy’ now currently defined as CTE (Gavett et al., 2011). In addition to 
repetitive head injury in sports, damages sustained from repeated exposure to 
blast explosions, as seen in veterans and civilians, and concussive injuries from 
persistent head banging and physical abuse are now widely recognized risk factors 
(McKee et al., 2013).  
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Clinical features and diagnosis of CTE  
The distressing manifestations of CTE usually present 8–10 years following 
repeated injury and include: progressive rage, impairments in memory, and 
visuospatial abnormalities (Gavett et al., 2011; McKee et al., 2013; McKee and 
Robinson, 2014). The pathology of CTE is defined by neurofibrillary tangles that 
are immunoreactive for abnormally hyperphosphorylated tau located around blood 
vessels and in an irregular pattern that is prevalent within the depths of sulci 
(McKee et al., 2016). Four clinical stages (depicted in Figure 4.1 and summarized 
in Table 4.1) have been established to characterize the progression of tau’s 
pathological accumulation in CTE (McKee et al., 2013). Although histological 
consensus exists among leading neuropathologists, definitive diagnoses can only 
be obtained from postmortem examination (McKee et al., 2016). Efforts to 
diagnose CTE during life and elucidate cellular mechanisms that contribute to 
injury progression are earnestly underway.  
 
Cellular mechanisms underlying CTE pathology  
Axonal injury is believed to underlie the pathology of CTE (Gavett et al., 2011; Giza 
and Hovda, 2014). Specifically, alterations in membrane permeability and 
concentrations of ions such as calcium that can promote release of caspases and 
calpains have been reported to initiate the misfolding, truncation, phosphorylation, 
and/or aggregation of tau proteins (Gavett et al., 2011). As detailed in Chapter 1, 
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tau proteins normally bind and stabilize microtubules (Figure 1.5) thereby aiding in 
neurite growth, axonal transport, and overall neuronal integrity (Johnson and 
Stoothoff, 2004; Ballatore et al., 2007; Wolfe, 2012). In addition tau has been 
reported to interact, directly and indirectly, with actin, the plasma membrane and 
the nucleus, as well as influencing the activity of proteins such as the scaffolding 
protein 14-3-3 and the membrane associated enzyme phospholipase Cɣ which 
ultimately affects signal transduction (Gendron and Petrucelli, 2009). With such 
extensive interactions among a variety of cellular components, disruption to tau 
homeostasis can result in devastating pathologies. 
The tau protein, encoded by the MAPT gene located on chromosome 17, 
can be alternatively spliced into six isoforms (Gendron and Petrucelli, 2009).  
Figure 4.2 depicts a basic schematic of the six isoforms of the tau protein. Two 
distinguishing features include the presence or absence of N-terminal acidic 
inserts as well as the number of C-terminal tubulin binding repeats (Ballatore et 
al., 2007). Post-translational modifications to tau are extensive and have been 
reported to include: acetylation, deamination, glycation, glycosylation, nitration, 
oxidation, phosphorylation, and ubiquitination (Avila et al., 2004). Despite such 
widespread modifications the most widely studied tau modification is 
phosphorylation. Several kinases and phosphatases are responsible for tau’s 
dynamic interaction with microtubules. Mutations, physical trauma, or alterations 
in signaling cascades that affect the rate of phosphorylation and dephosphorylation 
are reported to contribute to tau pathology (Ballatore et al., 2007; Gendron and 
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Petrucelli, 2009). The commonly cited pathological mechanisms include the toxic 
loss of function, due to tau’s inability to bind and stabilize microtubules when 
hyperphosphorylated, and the toxic gain of function due to tau’s ability to self-
aggregate and bind other proteins (Gendron and Petrucelli, 2009). The increased 
phosphorylation resulting in aggregation of tau proteins can interfere with 
intracellular trafficking culminating in degeneration as the efficient clearance of 
protein aggregates decline over time (Guo and Lee, 2014).  
Although tau proteins are normally intracellular there are reports of 
extracellular tau (Frost et al., 2009). Tau protein aggregates released from dying 
neurons are believed to account for extracellular tau (Hanger et al., 2014). In 
addition diffusion through membranes, release from synaptic vesicles and ruptured 
exosomes have also been speculated to contribute to extracellular tau (Wang and 
Mandelkow, 2016). The presence of extracellular tau can initiate glial activation. 
The over activation of glia can worsen over time as cellular cascades elicited from 
inflammatory mediators negatively affect surrounding neurons (Guo and Lee, 
2014).  
One hypothesis to explain the spatial and temporal progression of tau from 
discrete focal entities to wide-spread lesions involving many brain regions is trans-
synaptic propagation between neurons in anatomically connected regions (Wang 
and Mandelkow, 2016). Studies using cell cultures and intracerebral injections 
showing tau pathology in connected neural networks provide convincing evidence 
to support trans-synaptic spreading of tau pathology (Liu et al., 2012).  
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Another prevalent hypothesis to account for the spreading of tau is based 
on prion-like propagation (Costanzo and Zurzolo, 2013; Woerman et al., 2016). 
Pathological tau in CTE shares similarities with prion protein plaques in 
Creutzfeldt-Jakob disease, alpha-synuclein Parkinson’s disease, and amyloid-
beta and tau in Alzheimer’s disease, (Guo and Lee, 2014).  In a seminal study 
conducted by Dr. Stanley Pruisner’s group cell cultures infected with pathological 
tau, obtained from diagnosed cases of CTE and other neurodegenerative 
diseases, showed evidence of tau propagation in a prion-like manner (Woerman 
et al., 2016). In addition, animal models have shown that pathological tau can 
stability maintain specific conformations when introduced to different cell types and 
brain regions (Sanders et al., 2014). The implications from studies characterizing 
the cellular mechanisms that underlie CTE pathology will undoubtedly help in 
studies aimed at delaying the progression of neurodegeneration. 
 
Rationale for examining visual cortices in advanced CTE 
It has been estimated that 60% of those suffering from CTE show visual 
impairments ranging from blurred vision to complete vision loss (McKee, 2016).  
However, previous work indicates the relative absence of tau pathology in the 
primary visual cortex (Brodmann area (BA) 17) except in the most severe cases 
(McKee et al., 2013). It is believed that such sparing is due to the medial location 
of BA17 rendering it less vulnerable to physical trauma and thus cellular damage 
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that is a hallmark of CTE.  Although BA17 is relatively spared in CTE, visual 
association cortices (extrastriate cortex), such as BA 18 and 19, are vulnerable to 
tau pathology in neurodegenerative disorders such as AD (McKee et al., 2006). 
The highly complex connectivity, vascular, and metabolic features are believed to 
underlie neurodegeneration in extrastriate areas (Tong, 2003; McKee et al., 2006; 
Pikkarainen et al., 2009).  
Understandably pathologies involving tau and glia have received 
considerable attention in the CTE field (McKee et al., 2013; Cherry et al., 2016; 
Kanaan et al., 2016). However, few studies have explored whether tau 
preferentially accumulates in excitatory glutamatergic cells or in inhibitory 
GABAergic neurons (gamma-amino butyric acid, GABA). Morphologically, tau 
inclusions (neurofibrillary tangles) appear to affect pyramidal cells in CTE. In light 
of the axonal pathology that is believed to underlie CTE, it is likely that projection 
neurons such as pyramidal cells would be a vulnerable population. However, 
vulnerability of GABAergic neurons has been reported in AD, animal models of 
brain injury, and human postmortem examinations following TBI (Leuba et al., 
1998; Buritica et al., 2009). Based on the similarities between CTE and AD, it is 
advantageous to determine whether GABAergic neurons are affected in CTE. 
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Study objectives 
The first goal in this study was to characterize tau pathologies in visual cortices 
(BA17-19) in advanced (stages 3 and 4) CTE. The second goal was to determine 
whether a specific sub-class of GABAergic interneurons containing the calcium-
binding protein parvalbumin, was affected in advanced (stages 3 and 4) CTE. 
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Figure 4.1. Four clinical stages of CTE based on the progression of neurofibrillary 
tau pathology described in Table 4.1. Circles in Stage 1 indicate discrete, focal, 
clusters of phosphorylated tau labeled with CP13 antibody located primarily within 
the fundus of the sulcus. The prevalence of tau pathology in the depths of sulci 
increase (Stage 2) and spread to the superficial cortices of surrounding regions 
becoming increasing widespread in later stages (3 and 4). Figure modified from 
McKee et al., 2013. 
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Table 4.1. Description of the four clinical stages* of CTE
Stage Pathological description Affected brain regions
1 Discrete, focal clusters of 
phosphorylated tau in sulci 
depths and surrounding 
vasculature
Superior, dorsolateral, lateral 
frontal corties
2 Multiple focal clusters of 
phosphorylated tau in the 
depths of sulci
Superficial cortical layers of 
adjacent cortices in Stage 1
3 Widespread phosphorylated 
tau
Frontal, insular, temporal, 
parietal, amygdala, 
hippocampus, entorhinal 
cortices
4 Widespread, severe 
phosphorylated tau
Medial temporal lobe and most 
brain regions (primary visual 
cortex largely spared)
*As described in McKee et al., 2013 and McKee et al., 2016  
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Figure 4.2. Schematic of the six isoforms of tau protein. Black boxes represent the 
presence of repeat regions (3R, 4R). Orange and red boxes represent N-terminal 
inserts. Numbers flanking each isoform indicate the number of amino acids 
present. Schematic modified from Gendron and Petrucelli, 2009. 
  
107 
 
 
METHODS 
Subjects 
Coronal slabs of occipital lobes from fifteen subjects (7 controls, 4 stage 3 CTE, 4 
stage 4 CTE) were received from the Boston University Alzheimer Disease Center 
(BU-ADC) and Center for the Study of Traumatic Encephalopathy (CSTE) at 
Boston University School of Medicine. Tables 4.2a and 4.2b summarize general 
information on subjects evaluated in this study. 
 
Tissue preparation 
Occipital lobes were cryoprotected in progressive glycerol solutions as previously 
described (Rosene et al., 1986) and then dissected into smaller blocks 
(approximately 2 x 3 centimeters). Each dissected block contained multiple sulci 
and gyri for detailed histological characterization (Figure 4.3). The primary visual 
cortex (BA 17) was identified grossly by the stria of Gennari, a myelinated band of 
axons in layer 4. A distal extrastriate region located laterally within the occipital 
lobe, opposite the stria of Gennari, was selected from each subject to evaluate 
differences in the medial versus lateral visual cortices. Dissected tissue blocks 
were quickly frozen in 2-methylbutane at -80°C as previously described (Rosene 
et al., 1986). 
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Both regions of the visual cortices were cut into 40 µm thick slices using a 
freezing sliding microtome (Reichert Jung). Slices were collected in 15% glycerol 
in 0.1M PB in 16 uninterrupted series. Sections from each subject were maintained 
at -80°C until tissue from all subjects could be immunostained at the same time to 
avoid technical and procedural variability.  
 
Immunocytochemistry and histology 
For each antibody one uninterrupted series from striate and extrastriate regions 
from each subject were thawed overnight at 4°C and then brought to room 
temperature. Slices were processed free-floating with agitation. Prior to 
immunostaining sections were thoroughly rinsed in Tris Buffered Saline (TBS, pH 
7.6) (20mM Trizma base, 0.14M sodium chloride). To retrieve antigens masked 
during fixation, slices were first incubated in sodium citrate buffer (10mM sodium 
citrate, 0.05% Tween 20, pH 6.0) for twenty minutes at room temperature and then 
heated to 40°C using 550 Watts for 25 minutes with alternating 5 minute rest/heat 
cycles. Following heat-induced antigen retrieval slices were incubated at room 
temperature for 20 minutes in sodium citrate buffer and then rinsed in TBS. 
Endogenous peroxidase was quenched for 30 minutes at room temperature using 
3% hydrogen peroxide. Slices were incubated for one hour at room temperature in 
Superblock Blocking Buffer (Thermo Fisher, cat# 37515) to minimize non-specific 
binding. Following blocking sections were incubated in primary antisera (mouse 
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anti-CP13 1:500, gift from Dr. Peter Davies; rabbit anti-parvalbumin, Novus 
Biologicals, cat# NB120-11427) diluted in TBS containing 0.5% Superblock 
Blocking Buffer and 0.3% Triton-X100 for 48 hours at 4°C. Slices from a randomly 
chosen subject were processed simultaneously without the addition of primary 
antisera to ensure specificity of staining. 
 Following incubation in primary antisera, the tissues were washed in TBS 
and incubated in the appropriate secondary antisera (VectorLabs biotinylated goat 
anti-mouse (BA-9200) and biotinylated goat anti rabbit (BA-1000), both diluted to 
1:500 in TBS containing 0.3% Trition-X100) for one hour at room temperature. 
Slices were rinsed in TBS prior to incubation in avidin-biotinylated horseradish 
peroxidase (Vectastain Elite HRP Kit, cat# PK-6100, 1:500) for one hour at room 
temperature. Following TBS washes slices were simultaneously developed in 
0.05% 3,3-diaminobenzidine tetrahydrochloride (DAB) diluted in TBS and 0.005% 
hydrogen peroxide and rinsed in TBS. Free-floating sections were mounted and 
dried onto gelatin-subbed slides. Slide mounted slices were dehydrated in 
increasing alcohol solutions, cleared in xylene, and coverslipped in Permount 
(Fisher, cat# SP15). A subset of slides from each subject were defatted in 
chloroform:ethanol (1:1), rehydrated, and counterstained using 0.05% thionin (pH 
4.8) to stain Nissl substance as previously described (Giannaris and Rosene, 
2012). 
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Antibody Characterization 
The phosphorylation of several amino acid residues have been implicated in tau 
pathology (Figure 4.6). In this study, CP13, a monoclonal antibody (a generous gift 
from Dr. Peter Davies at Albert Einstein College of Medicine), that recognizes tau 
phosphorylated at serine 202 was used to characterize tau pathology. CP13 is one 
of three supported antibodies in the diagnosis of CTE (McKee et al., 2016). 
Additional studies supporting the specificity of CP13 have been published 
previously (Goldstein et al., 2012; McKee et al., 2013). 
A commercially obtained rabbit polyclonal parvalbumin antibody was used 
in this study to label a specific sub-class of GABAergic interneurons. Comparison 
of the staining quality and distribution of parvalbumin was analogous to previously 
published parvalbumin immunoreactivity in human striate and extrastriate cortices 
(Leuba et al., 1998; Buritica et al., 2009). 
 
Analysis 
Extrastriate identification 
The abrupt termination of the grossly visible stria of Gennari, in parvalbumin and 
thionin stained slices, was identified as the transition from BA 17 into BA 18 (Figure 
4.7). The extrastriate region opposite the calcrine sulcus was identified as BA 19 
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based on location and the laminar distributions of previously published 
cytoarchitectonic studies (Amunts et al., 2000; Amunts and Zilles, 2015). 
 
Semi-quantitative evaluation of CP13 phosphorylated tau 
Figure 4.4 depicts an example of the neuroanatomical regions-gyral crests and 
sulcal fundi-surveyed. Sulci and gyri with the greatest CP13 immunoreactivity in 
three to five slices from BA 17, 18, and 19 from each subject were analyzed. The 
four phosphorylated tau phenotypes of interest included: neurofibrillary tangles 
(NFTs), plaques, threads, as well as tau pathology associated with vasculature. 
Table 4.3 and Figure 4.5 detail the four pathological tau phenotypes evaluated. 
Characterization of NFTs and plaques were based on a previously described semi-
quantitative scoring system (McKee et al., 2006). Vasculature associated tau 
pathology was evaluated by calculating the ratio of vessels associated with tau 
pathology to the total number of vessels in a 10x field. Tau positive processes 
(threads) were scored based on the density within a 10x field. All coded subjects 
were re-coded to avoid bias and analyzed by a single experimenter blinded to the 
condition. 
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Design-based stereology 
The optical fractionator probe was used to obtain unbiased stereological estimates 
of parvalbumin positive cells in sulci and gyri in BA 17 and BA 19. Regions of 
interests were outlined using a 2x Nikon Plan objective using StereoInvestigator 
software (version 8.21.7, MBD Bioscience, Williston, VT). Table 4.4 summarizes 
stereological parameters used. All coded subjects were re-coded to avoid bias. 
Counts were performed at 20x by a single experimenter blinded to the conditions. 
The Gunderson coefficient of error (CE), was used to identify the precision 
(<0.1) of stereological estimates (Gundersen et al., 1999). The mean CE for BA 
19 Was 0.07 and 0.08 for sulci and gyri, respectively; for BA 17 the mean CE was 
0.07 for both sulci and gyri. With the exception of one outlier in BA 17 (CE = 0.14) 
CE values for each subject ranged from 0.04 to 0.09.  
 
Statistics 
A one-way analysis of variance and Pearson’s correlation were used to evaluate 
whether significant differences (p<0.05) were present among subjects (SPSS v24, 
IBM Corp.). Based on sample sizes less than 5 (for CTE stages 3 and 4), and the 
non-normal distribution, a Friedman test was used to evaluate differences in tau 
pathologies within advanced CTE groups across the three visual cortical areas. 
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Imaging 
Brain slices were imaged on a Nikon Eclipse motorized microscope (Nikon 
Instruments, Inc.) at 4x, 10x and 20x. ImageJ software (U.S. National Institutes of 
Health, Bethesda, Maryland, USA) was used to process the images.  
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Table 4.2a. Subject demographics
Subject Group Gender COD Repetitive trauma
Symptom 
Duration*
Age of Symptom 
Onset
1 Control Female
2 Control Male
3 Control Male
4 Control Female
5 Control Male
6 Control Female
7 Control Female
8 CTE Stage 3 Male Cerebrovascular disease Professional Football 4 80
9 CTE Stage 3 Male Dementia Professional Football 8 63
10 CTE Stage 3 Male Cancer Professional Football 23 48
11 CTE Stage 3 Male Cardiovascular disease Professional Football 58 27
12 CTE Stage 4 Male Dementia College Football 10 56
13 CTE Stage 4 Male Dementia Professional Football 5 64
14 CTE Stage 4 Male Dementia College Football 11 66
15 CTE Stage 4 Male Dementia College Football 15 50
Abbreviation: COD = Cause of death
* Duration determined by the difference between age at death and age of onset
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Table 4.2b.  Subject demographics (continued)
Subject Group Hemisphere
Brain 
Weight
Age PMI (hours) Fixation duration Fixation Type
1 Control Right 1170 87 Unknown 0.5 months Formalin then PLP
2 Control Right 1290 91 22.0 6 months PLP
3 Control Right 1600 91 2.5 6 months PLP
4 Control Right 940 83 6.5 4 months PLP
5 Control Right 1290 70 48.0 4.5 months PLP
6 Control Right 1080 87 12.8 4.5 months PLP
7 Control Right 1079 95 15.5 0.5 months PLP
8 CTE Stage 3 Left 1400 84 46.0 5.5 months Formalin then PLP
9 CTE Stage 3 Right 1219 71 17.0 4.5 months Formalin then PLP
10 CTE Stage 3 Right 1510 71 12.0 unknown Formalin then PLP
11 CTE Stage 3 Right 1060 79 120.0 5.5 months Formalin then PLP
12 CTE Stage 4 Right 1275 66 9.0 4 months Formalin then PLP
13 CTE Stage 4 Left 1390 69 36.0 7 months Formalin then PLP
14 CTE Stage 4 Left 1244 77 15.5 6 months Formalin then PLP
15 CTE Stage 4 Right 1265 65 30.5 3.5 months PLP
Abbreviations: PMI = Postmortem Interval, PLP =  Paraformaldehyde/Lysine/Periodate
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Figure 4.3. An example of a dissected and undissected occipital slab. The dashed black line indicates the location 
of the grossly visible stria of Gennari. Asterisk indicates the distal extrastriate area located opposite primary visual 
cortex that was chosen for comparative analyses. Scale bar = 10mm. 
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Figure 4.4. Neuroanatomical regions of interest. An example of a dissected tissue 
block depicting the regions of interest sulcal fundi (asterisks) and gyral crests 
(demi-circles) immunocytochemically evaluated. Dashed line indicates the location 
of the stria of Gennari. Scale bar = 5mm. 
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Figure 4.5. Section immunostained for CP13 indicating the four phenotypes of tau 
pathology semi-quantitatively evaluated. The CP13 antibody used was provided 
as a generous gift from Dr. Peter Davies. NFT = neurofibrillary tangle. Scale bar = 
100µm. 
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Table 4.3. Tau pathology evaluated
CP13 Phenotype Description Evaluation
Neurofibrillary tangle 
(NFT)*
Pre-tangles, intraneuronal tangles, 
extraneuronal tangles
0 (Absent); 1+(1/10x field); 2+ (2-5/10x field); 
3+ (6-9/10x field); 4+ (≥10/10x field)
Plaque* Aggregated tau
0 (Absent); 1+(1-9/10x field); 2+(10-19/10x 
field); 3+(20-32/10x field); 4+(≥33/10x field)
Threads* Tau positive processes
0 (Absent); 1+ (Sparse); 2+ (Moderate);     
3+ (Dense)
Vascular Association
Clusters of NFTs, plaques, and threads 
apposed to vasculature cross sections
Comparison of the ratio of vessels 
associated with phosphorylated tau 
*Semi-quantitative scoring stratification modified from McKee et al., 2006
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Figure 4.6. Schematic representation of key phosphorylation sites (left) in an 
arbitrary isoform of tau with the associated kinases (right). C = C terminal. CDK5 
= cyclin dependent kinase 5. GSK3b = glycogen synthase 3 beta. MAPK = 
mitogen-activated protein kinase. MARK = Microtubule affinity-regulating kinase. 
N = N terminal. PKA = protein kinase A. PKC = protein kinase C. S = serine. T = 
threonine. Schematic adapted from Wolfe, 2012. 
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Figure 4.7. A. Low magnification of parvalbumin stained brain slice depicting the prominent stria of Gennari 
(asterisks), scale bar = 3mm B. Inset from (A) revealing the abrupt termination of the densely immunoreactive band 
unique to the primary visual cortex (BA 17), scale bar = 100µm. The dashed vertical line represents the border 
between BA17 and the adjacent BA18. BA = Brodmann area. 
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Counting Frame Area (XY) (µm²) 14400.0
Disector Height (Z) (µm) 18.0
Disector Volume (XYZ) (µm³) 259200.0
Guard Zone Distance (µm) 2.0
Counting Frame Width (X) (µm) 120.0
Counting Frame Height (Y) (µm) 120.0
Sampling Grid (X) (µm) 838.0
Sampling Grid (Y) (µm) 666.0
Sampling Grid Area (XY) (µm²) 558108.0
Section Evaluation Interval 16
Table 4.4. Stereology parameters
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RESULTS 
Effect of subject parameters 
Parameters such as age, brain weight, and postmortem interval were evaluated 
on all 15 subjects to determine whether significant differences existed. The 
average age and standard deviation (SD) of control (n=7), stage 3 (n=4), and stage 
4 (n=4) groups were 86 (SD 8.13), 76 (SD 6.39) and 69 (SD 5.43), respectively. 
There was a statistical difference in the average age of control versus stage 4 
subjects (F(2,12)=7.705, p=0.007, Bonferroni post hoc analysis). Although a slight 
variation in brain weights existed, there were no statistically relevant correlations 
between brain weights and age (R=-.190, n=15, p=.498), health status (F(2,12) 
=.433, p=.658), postmortem interval (R=-.210, n=14, p=.471), or fixation duration 
(R=.477,n=14,p=.084) (Figure 4.6). Although one stage 3 subject had a 
substantially higher postmortem interval (120 hours), removal of this subject did 
not affect the correlation of brain weight and postmortem interval. Similarly, 
removal of the two outliers with fixation durations of 2 weeks did not result in a 
significant correlation between brain weight and fixation duration. The differences 
in postmortem interval did not differ significantly among groups (F(2,11)=1.456, 
p=.275) and were not correlated with the duration of fixation (R=.212, n=13, 
p=.487). 
 All of the CTE subjects were male and experienced repetitive head trauma 
from football. Interestingly, the overall duration of CTE symptoms were greater 
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among the stage 3 cohort compared to stage 4, (23.25 and 10.25 respectively) 
however the variation in symptom duration was greater among stage 3 (SD = 24.6) 
than the stage 4 (SD = 4.1). Of note is the fact that all of the stage 3 subjects 
played professional football whereas three of the four stage 4 subjects played 
college football and shared the same cause of death (dementia) (Table 4.2a).  
 
Tau pathology was present in visual association cortices despite sparing of 
the primary visual cortex 
The four phenotypes of tau pathology included: neurofibrillary tangles (NFTs), 
threads, plaques, and vascular association. Heat maps in Tables 4.5 and 4.6 
summarize the four tau phenotypes in sulci (Table 4.5) and gyri (Table 4.6). With 
the exception of one control subject, whose health status was unknown, all four 
phenotypes of tau pathology were absent in sulci and gyri of control subjects. 
Overall there was an increase in tau pathology in BA 18 and BA 19.  No tau 
pathology was observed in BA 17 for any of the subjects diagnosed with stage 3 
CTE in either the sulci or gyri. However, 50% of the stage 4 CTE subjects had 
evidence of some tau pathology in both the sulci and gyri in BA 17. In BA 18, 
plaques, NFTs, and threads, were present in 75% of stage 4 subjects whereas 
only 25% of stage 3 cases showed evidence of pathology. In BA 19 all of the stage 
4 CTE subjects had ≥ 10 tangles per 10x field whereas the scores for tangles 
present in the gyri in BA 19 varied from 1+ to 3+.  The presence of vascular 
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associated pathology in BA 18 and BA 19 was in general highly varied in both 
stage 3 and stage 4 subjects. Vascular association of tau was present in 50% of 
the stage 4 cases to the same extent in both sulci and gyri.  
 
Average number of parvalbumin cells unaffected in advanced CTE 
No significance difference was observed in the mean density (cell count/mm3) of 
cells immunocytochemically labeled for the calcium-binding protein parvalbumin 
(Figure 4.9) within sulci and gyri of the primary visual cortex (sulci, F(2,11)=.896, 
n=14, p=.436; gyri F(2,11)=.757, n=14, p=.492) or extrastriate cortex (sulci, 
F(2,11)=.888, n=14, p=.439; gyri F(2,11)= 3.008, n=14, p=.091) of control, stage 3 
and stage 4 subjects (Figure 4.10).  
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Figure 4.8. Differences in brain weights were not correlated with age (A), PMI (B), group (C), or duration of fixation 
(D). Error bars in (C) represent SD (control = 7, stage 3 = 4, stage 4 = 4). PMI = postmortem interval. 
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Table 4.5 Heat map of phosphorylated tau pathology within the depths of sulci across  brain regions
Coded Subject Group BA17 BA18 BA19 BA17 BA18 BA19 BA17 BA18 BA19 BA17 BA18 BA19
1 Control 0 0 0 0 0 0 0 0 0 0 0 0
2 Control 0 0 0 0 0 0 0 0 0 0 0 0
3 Control 0 0 0 0 0 0 0 0 0 0 0 0
4 Control 0 0 0 0 0 0 0 0 0 0 0 0
5 Control 0 0 0 0 0 0 0 0 0 0 0 0
6 Control 1 1 3 1 1 4 1 1 2 9 0 27
7 Control 0 0 0 0 0 0 0 0 0 0 0 0
8 CTE Stage 3 0 0 0 0 0 0 0 0 0 0 0 0
9 CTE Stage 3 0 2 3 0 4 4 0 1 1 0 9 29
10 CTE Stage 3 0 0 1 0 0 1 0 0 1 0 0 6
11 CTE Stage 3 0 0 1 0 0 4 0 0 1 0 0 26
12 CTE Stage 4 2 2 1 4 4 4 1 2 2 19 11 13
13 CTE Stage 4 0 1 1 0 4 4 0 1 2 0 0 27
14 CTE Stage 4 1 1 1 2 4 4 1 2 2 17 17 18
15 CTE Stage 4 0 0 0 0 0 4 0 0 2 0 0 0
Plaques NFTs Threads Vascular Association
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Coded Subject Group BA17 BA18 BA19 BA17 BA18 BA19 BA17 BA18 BA19 BA17 BA18 BA19
1 Control 0 0 0 0 0 0 0 0 0 0 0 0
2 Control 0 0 0 0 0 0 0 0 0 0 0 0
3 Control 0 0 0 0 0 0 0 0 0 0 0 0
4 Control 0 0 0 0 0 0 0 0 0 0 0 0
5 Control 0 0 0 0 0 0 0 0 0 0 0 0
6 Control 3 1 1 1 2 1 1 1 1 8 18 0
7 Control 0 0 0 0 0 0 0 0 0 0 0 0
8 CTE Stage 3 0 0 0 0 0 0 0 0 0 0 0 0
9 CTE Stage 3 0 2 1 0 4 1 0 1 1 0 14 2
10 CTE Stage 3 0 0 1 0 0 1 0 0 1 0 0 0
11 CTE Stage 3 0 0 1 0 0 0 0 0 0 0 0 3
12 CTE Stage 4 1 3 1 2 4 3 1 2 3 14 26 33
13 CTE Stage 4 0 1 1 0 4 1 0 1 1 0 23 13
14 CTE Stage 4 1 1 1 1 4 2 1 2 2 15 28 18
15 CTE Stage 4 0 0 0 0 0 2 0 0 2 0 0 42
Table 4.6. Heat map of phosphorylated tau pathology within gyral crowns across  brain regions
Plaques NFTs Threads Vascular Association
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Figure 4.9.  Low magnification of parvalbumin in primary visual cortex (A) and 
extrastriate cortex (B). Roman numerals in (A) denote cortical layers. Scale bar = 
100µm. 
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Figure 4.10. There was no change in the average number of parvalbumin positive cells within the sulci and gyri in 
the primary visual cortex (striate) (A and C) or visual association cortex (extrastriate) (B and D). Error bars represent 
SD (control = 7, stage 3 = 4, stage 4 = 4). 
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DISCUSSION 
No change in the overall number of cells immunoreactive for parvalbumin was 
apparent in the sulci or gyri in BA 17 and BA 19. However, semi-quantitative 
analyses revealed a progressive increase in tau pathology in BA 18 and BA 19, 
despite sparing of primary visual cortex, BA 17. Although a similar progressive 
trend was apparent, the extent of tau pathology, particularly NFTs and tau positive 
processes, was greatest in the sulci. As expected, the general increase in tau 
pathology correlated with advancing CTE stage.  
 
Tau pathology in the visual cortex of neurodegenerative diseases 
The results of this study are similar to previous studies reporting that the visual 
cortex is largely spared tau pathology in CTE (McKee et al., 2013) and AD (McKee 
et al., 2006). It has been speculated that the medial location of the primary visual 
cortex is likely to underlie sparing, particularly in CTE.  
Visual cortices are not among the common brain regions examined in the 
postmortem diagnosis of CTE. It is believed that the presence of pathological 
lesions in the visual cortex occurs during the last stages of the disease or early on 
in the most severe forms (McKee et al., 2006; McKee et al., 2013). Although tau 
pathology is often largely absent in the primary visual cortex, visual association 
areas are vulnerable (Pikkarainen et al., 2009). Work by Braak reported a striking 
increase in NFTs when transitioning from striate to parastriate cortex (BA 17 to BA 
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18) and from parastriate to peristriate cortex (BA 18 to BA 19) (Braak et al., 1989). 
Similarly, in this study, progressing from the primary visual cortex to visual 
association areas, there was an increase in the extent of the tau pathology present. 
Although the small sample size precludes the power needed to robustly analyze 
the correlation of pathology across brain regions, there is sufficient preliminary 
evidence to support a more detailed examination with a larger sample size. 
The primary visual cortex is a well-characterized brain region that is most 
easily identified by the myelinated band of axons in layer 4 (stria of Gennari). It 
represents a pivotal point in the visual pathway, where information received from 
the lateral geniculate nucleus is organized and distributed to higher order visual 
association regions (Nolte and Sundsten, 2002). Less is known regarding visual 
processing in association cortices. However, the higher metabolic demands, and 
differences in proximity to vascular supplies are speculated to render this region 
susceptible to pathology in disease states (McKee et al., 2006). Based on the 
perivascular presence of pathological tau it is possible that some of the visual 
impairments reported in CTE could result from the pathology in the visual 
association cortex. However, additional work is needed to document the status of 
cells and the presence of tau co-localization in these visual association regions.  
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Parvalbumin in neurodegeneration and TBI 
The vulnerability of parvalbumin cells in neurodegeneration is still somewhat 
inconsistent. Several neurodegenerative studies have reported no change in the 
overall number of parvalbumin cells in diseases such as AD (Hof et al., 1991; 
Iwamoto and Emson, 1991; Ferrer et al., 1993; Leuba et al., 1998), frontotemporal 
dementia, and Pick’s disease (Arai et al., 1991). However, other studies have 
found subtle changes in parvalbumin cells. For example, one study found a small 
percentage (4%) of parvalbumin cells that co-localized with tau compared to 20–
31% of pyramidal cells (Iwamoto and Emson, 1991). There are several 
explanations that could account for the stability of parvalbumin positive 
interneurons. However, the simplest explanation may relate to their size. 
Parvalbumin positive neurons are approximately 10 µm in diameter (Blumcke et 
al., 1990) which is noticeably smaller than the larger projection neurons that are 
likely to be more vulnerable to the DAI occurring from repetitive trauma. Analysis 
of the pyramidal cells containing NFTs suggests that smaller cells are less likely to 
accumulate tau. There have also been reports of significant losses of parvalbumin 
positive cells (Arai et al., 1987; Satoh et al., 1991). Although some studies reported 
no overall changes in parvalbumin cells, there can be subtle losses in specific 
cortical layers despite no change in total cell number (Leuba et al., 1998). In 
addition, dystrophic and degeneration of processes have been reported (Ferrer et 
al., 1993).  
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Despite the stability of parvalbumin cells in the visual cortices in this study, 
the evaluation of parvalbumin in brain regions highly vulnerable to damage in CTE 
would be of interest as calcium ions affect the production and release of 
neurotransmitters, axonal transport and neuronal excitability (Arai et al., 1991). 
Calcium-binding proteins such as parvalbumin have been shown to play an integral 
role buffering and redistributing intracellular calcium (Arai et al., 1991). Although 
dysregulation of calcium in TBI and neurodegenerative disorders such as AD has 
been widely published (Bezprozvanny and Mattson, 2008; Wojda et al., 2008), no 
CTE study to date has examined potential changes in the immunoreactivity of 
parvalbumin, or any other calcium-binding protein.  
The present lack of detectable changes in the number of parvalbumin 
neurons indicates that any effect of CTE on GABAergic neurons is not universal. 
It is unknown whether cells containing parvalbumin are uniquely spared. One 
possibility is parvalbumin’s unique role as a powerful calcium-binding protein 
(Marambaud et al., 2009). Perhaps over time increases in the amount of 
intracellular calcium ions, either due to transient perforations in cells or disrupted 
intracellular stores from the mild and repetitive brain injuries could be resolved by 
the buffering and binding of calcium-binding proteins within the cell.  Thus, at the 
onset of CTE symptoms cell types that do not possess the capacity to mitigate the 
cascades that result from mechanisms associated with ion toxicity could be 
vulnerable in the disease state.  
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A more detailed examination of potential cell-specific vulnerability perhaps 
in other sub-classes of GABAergic neurons across all four clinical stages of CTE 
within different brain regions will be useful in future studies. It is becoming 
increasingly evident that GABAergic neurotransmission is affected in 
neurodegeneration (Abbas et al., 2016; Palop and Mucke, 2016). Alterations in 
GABAergic networks may either play a primary role or may result from aberrations 
in excitatory signaling (Li et al., 2016). Although the results of this study revealed 
no change in the number of parvalbumin immunoreactive cells in the primary visual 
cortex and visual association cortex, it will be essential for future studies to 
examine whether there are alterations in GABAergic receptors in the sulci and gyri 
of primary and associative visual cortices that are affected in CTE. In addition to 
histopathological evaluations, assessing the functional status of interneurons, 
despite their apparent resistance, will also be of value especially in the 
development of therapeutic targets to mitigate the onset and progression of CTE 
and related tauopathies.   
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CHAPTER 5 
DISCUSSION 
 
Summary 
Most of the animal models to date used to study TBI employ invasive methods that 
result in moderate and severe damage. However, mild TBI accounts for the 
majority of all injuries and has been associated with CTE. Few studies have probed 
the region-specific status of specific cell populations following mild blast exposures 
in animal models and none have examined vulnerability of specific interneuronal 
populations in CTE. Therefore, the results of this work offer valuable insight 
regarding region-specific vulnerability to mild blast and advanced CTE. 
 
Technical considerations in animal models of blast 
The extent of injury due to blast exposure has been associated with the magnitude 
and duration of pressure experienced (Svetlov et al., 2009; Kuehn et al., 2011; 
Rosenfeld et al., 2013; Mishra et al., 2016). However, as stated in the introduction 
(Chapter 1), there can be different outcomes due to differences in model 
construction (Koliatsos et al., 2011; Hines-Beard et al., 2012; Heldt et al., 2014), 
the presence of anesthetics (Kawaguchi et al., 2005; Statler et al., 2006; Rowe et 
137 
 
 
1
3
7
 
al., 2013), the animals used (Xiong et al., 2013), the orientation to blasts (DeMar 
et al., 2016; Guley et al., 2016), and the time points examined following insults.  
To overcome the glaring anatomical differences and relate the injuries 
experienced by rodents with humans scaling laws have been developed (O'Connor 
et al., 2011; Jean et al., 2014; Wang et al., 2014). However, there remains 
considerable variability among studies and although head acceleration does 
appear to affect injury outcome some question the complications it may exert 
(Gullotti et al., 2014). To carefully account for the contributions of head 
accelerations high-speed cameras capturing movement of the animal during 
primary blast exposure, and kinematic calculations are necessary. Despite careful 
attention to such details without implanted tissue sensors, the full extent of head 
mobility is not always possible. Thus, although blast models offer considerable 
clinical relevance to injuries sustained in special risk groups, there are inherent 
limitations that may not be possible to fully resolve in animal models of blast. 
 
Direct cranial blast model technical considerations 
The rodent model of direct cranial blast used in this work was adapted from a 
previous blast protocol using anesthetized rats (Kuehn et al., 2011). The average 
maximum blast pressure recorded in this study was 1,034 kPa, which differed 
greatly from the 515 kPa reported by Kuehn and colleagues. Calibration of the 
COBIA used a sensor with a 100 kHz maximum sampling frequency. To get a 
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sense of how the blast wave would have been altered over a larger area, 
analogous to the dorsal surface of the animal two filters, 2kHz and 12kHz, were 
used. Both filters were based on methodologies used in two previously published 
blast studies. The 12 kHz filter was used to more directly compare to the pressure 
reported by Kuehn and associates in their COBIA validated in rats (Kuehn et al., 
2011). The pressures filtered at 12 kHz resulted in a notably lower mean pressure 
of 322 kPa, which was more comparable to the 515 kPa reported by Kuehn et al. 
Use of the 2kHz filter resulted in an average pressure of 178 kPa which was similar 
to the 77kPa reported by Goldstein et al. (2012) following a 2-kHz low pass filter in 
a shock tube model of mild blast injury in mice. Aside from the difference in blast 
source (modified nail gun versus shock tube) and animals used (rats versus mice), 
the presence of head movement is a key difference. In the direct cranial blast 
model anesthetized rats were immobilized under the COBIA whereas animals in 
the study conducted by Goldstein et al., were not. In spite of these differences 
based on the similarities among the magnitude of blast pressures when various 
frequency filters were applied, and the subtle structural changes observed in blast 
exposed mice compare to sham, the blast pressures used in this work were 
considered to recapitulate mild blast(s). 
As additional studies focused on blast injury emerges the motivation, to 
ensure the appropriate application and interpretation of results remain (Panzer et 
al., 2012; Panzer et al., 2014). A key question that has been posed is whether 
unrealistic blasts that cause considerable damage in animal models are relevant 
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to humans (Panzer et al., 2014). Figure 5.1 provides a visual comparison of how 
the blast pressures used in this study may compare with those previously reported. 
Based on the peak pressure and scaled duration, the blasts used in this study are 
within the range of realistic blast exposure. The fact that the blasts in this study are 
at the low end of the range of realistic blasts further supports the fact that despite 
a large incident pressure the results obtained simulate responses to mild blasts. It 
is important to note, however, that all of the studies displayed in Figure 5.1 
(modified from work by Panzer et al. in 2014) used a shock tube. In addition, of 
interest is the fact that several of the reported studies highlighted (Saljo et al., 2010; 
Cernak et al., 2011; Goldstein et al., 2012; Vandevord et al., 2012) were cited as 
outside the range of realistic blast exposure. 
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Figure 5.1. Comparisons of peak incident pressure versus scaled durations for 
multiple animal models of TBI due to blast from studies employing shock tubes. 
The shaded blue region (left) depicts the range of realistic blast exposures while 
the area enclosed by the dashed orange line (right) depicts published studies 
whose scaled human exposures are outside of the estimated range of realistic 
blasts. The black star represents the exposure believed to be represented in the 
present work despite differences in apparatus used (COBIA used in this study 
versus shock tube). Image modified from Panzer et al., 2014. 
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Blast Intervals in a repetitive injury paradigm 
An important component of this work was the incorporation of multiple blasts. 
Within the last decade, it has become increasingly evident that incorporating 
exposure to multiple blasts can offer better insight into TBI pathology as injuries to 
soldiers and civilians are often due to repetitive insults (Wang et al., 2011). The 
increased vulnerability following multiple insults is believed to result from a 
combination of reduced injury thresholds and increased severity of injury due to 
incomplete cellular recovery between insults (Wang et al., 2011; Gao et al., 2017). 
Although repetitive injury paradigms have considerable clinical relevance, 
there is significant variability among the insult intervals (Wang et al., 2011; Bolton 
and Saatman, 2014; Lynch et al., 2016; Ferguson et al., 2017). One study 
evaluated damages sustained from repeated injuries that occurred minutes apart 
(Wang et al., 2011) while others report injury intervals ranging from 24 to 48 hours 
(Bolton and Saatman, 2014; Lynch et al., 2016). The choice to utilize a 24 hour 
latency between blasts was based on a previously published CCI model in mice 
(Bolton and Saatman, 2014). Behavioral assessments (righting reflexes) and 
histopathology results comparing a single mild insult to multiple impacts (n=5) with 
24 and 48 hour intervals revealed increased gliosis and neurodegeneration when 
injuries occurred 24 hours apart (Bolton and Saatman, 2014). However, the results 
of this study did not reveal evidence of a dose response in the neuronal and glial 
populations examined. One explanation is that the optimal interval to study the 
effect of repetitive insults could depend on the mode of injury. Most of the published 
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reports of repeated trauma are based on cortical impact models (Wang et al., 2011; 
Bolton and Saatman, 2014; Ferguson et al., 2017). Although the reproducibility of 
impact models is an advantage, they can be invasive and often involve use of 
anesthetics. In addition, the mechanism of focal trauma versus diffuse axonal 
injury due to shearing and stretching of neurons during blast compared to impact 
may effect on injury progression. Therefore, the results of this study provide useful 
and novel insight into the effect of mild blasts directed onto the dorsal surface of 
the cranium in unanesthetized wild-type mice. 
Although the immunocytochemical evaluation regarding how and where 
cells seem to be affected following mild blast injury left many questions, the novelty 
of this blast model adapted for use in mice and the results of this study do provide 
a good starting point for future studies. 
 
Considerations for future studies  
Aim 1: Immunocytochemical evaluation of neuronal and glial responses in the 
mouse hippocampus following single and repeated blast exposures. (Chapter 2) 
 
The subtle anatomical alterations reported in this study reveal a unique region 
specific response in the hippocampus. Glial alterations were observed following 
acute recovery to both a single and repeated blasts. However, it is possible that 
the full extent of the pathologies produced by the short duration of blast may have 
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resolved between the 24 hour intervals or within the recovery windows examined.  
It would be of great interest for future studies to identify whether 
hypertrophic microglia are restricted to the outer molecular layer at more acute 
time points (minutes to hours) or whether hypertrophic cells are initially widespread 
within the hippocampus and become limited to the outer molecular layer of the 
dentate gyrus. There was no positive immunostaining with known pathological glial 
mediators. Additional efforts to identify the nature of the glial hypertrophy 
(neuroprotective versus neurotoxic) are warranted. 
Although the glial results of this aim provided the greatest evidence of a 
cellular response, collaborative work using in vivo calcium imaging within CA1 
showed a decrease in intracellular calcium (data not shown). This decrease was 
evident in individual cells as well as an overall reduction in spike activity (data not 
shown). The occurrence of such pronounced yet subtle changes could provide a 
basis for more detailed work regarding the specific cell populations affected. It 
would also be valuable to incorporate molecular techniques to provide insight 
regarding potential changes in gene expression following acute and chronic 
exposures following mild blast.   
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Aim 2: Immunocytochemical examination of glial morphologies following exposure 
to mild repetitive blasts in the brain and retina. (Chapter 3) 
 
Most of the blast-related studies reporting retinal pathology have used models of 
direct ocular injury (blasts directed onto the eye), rather than the cranium (Choi et 
al., 2014; Bricker-Anthony et al., 2016; DeMar et al., 2016). The absence of 
hypertrophic glia in this study suggest that either the blast pressures, recovery time 
points, and/or animal orientation with respect to blast, were insufficient to result in 
glial activation within major visual structures. Although this study did not 
specifically evaluate the status of neurons within the retina, collaborative work 
evaluating the functional integrity of the retina using electroretinograms detected 
only slight decreases in scotopic responses (contrast sensitivity), one month 
following exposure to a single blast (data not included). In addition, there were 
slight decreases in the density of retinal ganglion cells one month following a single 
blast (data not included).  However, even with increased sample sizes, the level of 
variability between blast and sham groups did not result in statistically significant 
changes.  
Although the mouse retina projects to approximately 46 different brain 
regions (Morin and Studholme, 2014) only 3 regions (DLG, SC, and visual cortex) 
were examined in this study. Similar to the retina, no structural changes in glia 
were observed in the central visual brain regions examined. However, it would be 
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worthwhile to evaluate potential changes in the functionality of the retina and 
central visual regions at more acute time points.  
 It is parsimonious to assume the blasts were insufficient to cause damage 
or that cellular recovery had occurred by the time points examined. However, the 
lack of change in both the numbers and appearances of the neurons containing 
the calcium-binding proteins calretinin and parvalbumin could partially result from 
a cell-specific resistance to mild blasts. Evaluation of receptors or synaptic proteins 
may detect subtle neurochemical and anatomical changes following mild blasts. In 
addition, simple behavioral tests to assess subtle physiological impairments, such 
as the righting reflex used to assess basic sensory and motor functionality, would 
be beneficial to correlate with the immunocytochemical results. 
 
Aim 3: Immunocytochemical evaluation of tau pathology and parvalbumin within 
visual cortices in advanced chronic traumatic encephalopathy. (Chapter 4) 
 
The only CTE study to date that evaluated tau pathology within a central visual 
pathway was work by Armstrong and colleagues (Armstrong et al., 2017).  Their 
results indicated that the tau pathology preferentially affected the intermediate and 
lower regions of the superior colliculus suggesting motor abnormalities rather than 
sensory deficits. However, visual impairments are reported in approximately 60% 
(McKee, 2016) of CTE sufferers and there are no studies that have evaluated the 
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visual cortex beyond the primary visual cortex. It is likely that the absence of tau 
pathology in the primary visual cortex, except in the most severe cases (McKee et 
al., 2013) has motivated efforts to focus on more vulnerable brain regions. 
However, the presence of tau pathology in visual association areas in this study 
provides an impetus to explore, in greater detail with a larger sample size, how the 
central visual pathways may be affected during the course of the disease.  
Previous work presented at the Association for Research in Vision and 
Ophthalmology indicated preliminary evidence of tau aggregates in the retinas of 
patients diagnosed with CTE (McKee, 2015). It was speculated that the tau present 
in the retina may be an early diagnostic feature of CTE. Although CTE is distinct 
from other neurodegenerative disorders, the similarities it shares with AD could 
help direct future studies. For example, retinal pathology has been reported in AD. 
Interestingly, the retinal pathology present in AD cases has been reported to 
precede brain pathology, particularly in the early stages (Kirbas et al., 2013). 
Therefore it is possible that the retina could serve as a useful proxy in CTE, 
especially due to the delayed onset of symptoms (Mez et al., 2015). Future studies 
to systematically examine the progression of tau pathology in the retina and central 
visual pathways across all four clinical stages of CTE will undoubtedly be of value. 
The cross-sectional nature of early CTE studies represented a limitation in 
the field. However, the correlation of radioactive deposits from functional brain 
imaging studies (which often lack the resolution with histopathology) has enabled 
considerable progress in the field to date. Use of positron emission tomography 
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(PET) imaging has shown promise in detecting brain aggregates whose spatial 
pattern is analogous to the histological patterns of hyperphosphorylated tau 
observed postmortem (Barrio et al., 2015). In addition, there have been reports 
detailing a genetic component because not all individuals with histories of repetitive 
head trauma will develop CTE (Mez et al., 2013).  
The number of parvalbumin cells in this study did not differ between control 
subjects and those with advanced CTE, in either the primary visual cortex or visual 
association areas. It is possible that parvalbumin cells are spared from tau 
pathology. Although large projection neurons have a higher likelihood of tau 
accumulation, a more comprehensive characterization of the potential vulnerability 
of different laminar regions and potential changes in other interneuronal 
populations is warranted. For example, although the primary visual cortex is largely 
spared from CTE pathology, it would be worthwhile to explore in detail whether 
cells forming the stria of Gennari, which receives and integrates thalamic input is 
affected. Furthermore, as discussed in Chapter 4, evaluation of cellular markers to 
detect subtle changes such as surface receptors and synapses in cells that appear 
spared would be advantageous.   
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